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PREFACE
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“Biochemistry 2011, 50 (39), pp 8342–8351.” Entire data was produced in Dr. Wan Jin
Jahng’s laboratory in Department of Biological Sciences, Michigan Technological
University. Dr. Jahng was the corresponding author. He conducted data analysis and
revised the manuscript.
The material used in chapter 3 of this dissertation was reproduced in its entirety with kind
permission from Scientific Research Publishing Inc. “Adavances in Bioscience and
Biotechnology 2012, 3(8), pp 1167-1178.”Entire data was produced in Dr. Wan Jin
Jahng, Dr. Ramakrishna Wusirika and Dr. Megan C. Frost laboratory in Department of
Biological Sciences and Department of Biomedical Engineering Michigan Technological
University. Dr. Jahng and Dr. Frost were the corresponding authors. Dr. Jahng conducted
data analysis and revised the manuscript.
The data for the material used in chapter 4 of this dissertation was produced in Dr. Wan
Jin Jahng and Dr. Ramakrishna Wusirika laboratory in the Department of Biological
Sciences, Michigan Technological University. Dr. Jahng is the corresponding author. Dr.
Jahng conducted data analysis and revised the manuscript.
Role of other authors
Figures 2.2 to 2.6 from chapter 2, figures 3.1 and 3.6 from chapter 3 and figures 4.8,
4.10 and 4.11 are generated by Weilue He from chapter 4. Table 4.1 from chapter 4 was
analyzed and prepared by Ji-Yeon Um.
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ABSTRACT
Oxidative stress, intense light exposure and oxygen imbalances such as hypoxic or
hyperoxic conditions perturb mitochondria, nuclear function and further lead to cellular
damage of retina and retinal pigment epithelial (RPE) cells. Our major aim is to
understand the various biochemical and proteomic events that occur during the
progression of retina and RPE cell death. The comprehensive objectives of this
dissertation are to understand the functional aspects of protein expression,
posttranslational modifications,

protein or

lipid

binding

changes,

phenotypic,

morphological alterations and their regulation during the retina and RPE apoptosis under
oxidative stress. The entire study is divided into four chapters Chapter 1 contains
introduction and background on apoptotic signaling in retina and RPE cells. In chapter 2,
we demonstrated that the oxidative stress biomarker prohibitin shuttles between
mitochondria and nucleus as an anti-apoptotic molecule and acts as a transcriptional
regulator by altering its lipid binding affinity and by posttranslational modifications
during oxidative damage to the retina and RPE. In chapter 3, we demonstrated that
oxidative and photo-oxidative stress induced nitric oxide regulates the RPE apoptosis by
altering serine/threonine protein phosphatase 2A (PP2A) catalytic subunit, vimentin
phosphorylation and Bcl xL expression regulation in the RPE cells in vitro. In chapter 4,
we further analyzed the differential expression of prohibitin in the retina and RPE during
oxidative stress, diabetic retinopathy (DR) and age-related macular degeneration (AMD)
condition. Our analysis of postmortem retinas reveals that prohibitin is significantly
increased in aged and AMD retina, and decreased in retinas of human diabetic
retinopathy and RPE of AMD. Our study demonstrates that prohibitin levels determine
the apoptotic signaling in the retina and RPE during retinal degenerative disease
progression.
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CHAPTER 1: INTRODUCTION AND BACKGROUND
Eye is a complex organ of the human body which contains different parts with various
functions indispensable for clear vision. The front portion of the eye with transparent
dome shaped structure which covers the iris and pupil is called cornea. Cornea helps in
protecting the inner parts of the eye and focuses the light that enters the eye. Lens is
another transparent oval shaped body compacted with crystalline, which directs the
movement of light towards the retina to initiate the visual transduction. The vitreous
humor is clear and colorless substance within the anterior chamber that fills the space
between lens and retina. Retina is the neural portion of the eye which comprises of
different classes of neurons such as photoreceptors (rods and cones), bipolar cells,
ganglion cells, horizontal cells and amacrine cells. Retina is connected to the central
nervous system. Retinal pigment epithelium (RPE) is the single layer of cells located
underneath the neurosensory retina firmly attaching to the choroid.
1.1. Role of oxidative stress in the retina and RPE during the progression of retinal
degenerative diseases
Retinal pigment epithelium (RPE) is highly pigmented, hexagonally packed cuboidal
monolayered epithelium located on the Bruch’s membrane between the neural retina and
the choriocapillaries. RPE performs various functions such as phagocytosis of
photoreceptor outer segments, transportation of nutrients, protection against reactive
oxygen species, synthesis of vitamin-A metabolites (retinoid recycling) and maintaining
the retina blood barrier which are highly indispensable for sustaining vision (Zangwill et
al., 2000). High metabolic activities and visual signal transduction process in the retina,
especially in macula contributes high oxygen tension in RPE (Alder and Cringle, 1985).
Although the retina and RPE have powerful oxygen regulating mechanism, formation of
reactive oxygen species (ROS) are predictable during pathophysiological conditions of
Age-related macular degeneration (AMD), retinitis pigmentosa (RP), diabetic retinopathy
(DR) and retinopathy of prematurity (ROP). Intense light exposure has been linked to the
ocular damage which may cause the development of AMD, possibly due to the oxidative
damage to the RPE layer (Taylor et al., 1992). Frequency of retinal irradiation, presence
10

of chromophores/photo sensitizers, oxidation of poly unsaturated fatty acids (PUFA) such
as Docohexanoic acids (DHA) in RPE provide an ideal environment for the generation
of ROS (Beatty et al., 2000). Lack of protective mechanism against the oxidative damage
may initiate the choroidal neovascularization in mouse model (Dong et al., 2009).
Although the accumulation of photo-toxic ROS, lipo-protein complexes (drusen) suggests
a correlation between oxidative stress and AMD, the mechanism of RPE apoptosis under
oxidative stress is elusive. We speculated that identification of oxidative stress induced
biomarkers in the retina and RPE provides novel insights towards signaling mechanism
of retinal degeneration at the molecular level. Since oxidative stress contributes the
progressive cell death of retina and RPE, our previous research team performed the
proteomic analysis from bovine and human RPE cells under oxidative stress environment
(Arnouk et al., 2011a). They found that aging related mitochondrial protein prohibitin is
down-regulated in the bovine RPE cells along with the differential expression of several
other proteins such as apoptotic related, DNA repair, respiratory chain related proteins
(COX). Our later studies focused on the multifunctional protein prohibitin in the retina
and RPE under elevated oxidative stress. Our proteomic approaches revealed that
prohibitin is down regulated in the RPE, where as it was upregulated in the retina from
aged and diabetic rat model. Our further proteomic studies confirm the tissue specific and
sub cellular localization (mitochondria and nucleus) of prohibitin in the retina (ganglion
cell, outer and inner nuclear layer) and RPE. (Lee et al., 2010a). Subsequently, we are
interested in the functional role of prohibitin and its regulation in the RPE under
oxidative. Our proteomic analysis provides the evidence that prohibitin communicates
between the mitochondria and nucleus, acts as an anti-apoptotic molecule and
transcription regulator in the retina and RPE under oxidative stress (Sripathi et al.,
2011a).
1.2 Multifunctional role of prohibitin (PHB) in the retina and retinal pigment
epithelium (RPE) under oxidative stress
Prohibitin is a highly conserved mitochondrial membrane protein with the molecular
mass of` 30-32 kDa, located on chromosome 17 at q21. The amino acid sequence of
11

prohibitin in rat and mouse are identical and differ from the human prohibitin sequence
by single amino acid (Mcclung et al., 1995b). The prohibitin complex (PHB1, PHB2)
have been identified in mitochondria and plasma membrane as they both bind together
to form a heterodimer and

anchor to inner mitochondrial membrane through N

terminalhydrophobic regions present in PHB1 and PHB2 (Artal-Sanz and Tavernarakis,
2010). Prohibitin acts as a potential tumor suppressor with anti-proliferative activity by
regulating the cell cycle progression and apoptosis (Nuell et al., 1991). PHB1 co
localizes in the nucleus with E2F1, retinoblastoma protein pRb2 and p53 to modulate
transcriptional activity and recruit HDAC1 towards the repression of histone
deacetylation (Wang et al., 2002a). Differential expression, regulation of both
mitochondrial and nuclear genes may alter the sub cellular translocalization and
function of a protein. Nuclear genes enable the mitochondrial- nuclear shuttling as seen
in case of breast cancer cell lines (Delsite et al., 2002).
Irrespective of various cancers, neurodegenerative diseases, functional aspects of
prohibitin in the eye are not well studied yet. The multifunctional protein prohibitin is
significantly down regulated in bovine and human RPE cells under oxidative stress
(Arnouk et al., 2011a). Our proteomic studies reveal that prohibitin is involved in the
oxidative stress induced cell signaling and is identified as an oxidative stress biomarker
in the retina and RPE. Prohibitin expression is controlled by oxidative, light induced
stress and shows the differential expression levels in aged and diabetic retina (Lee et al.,
2010a). We found that prohibitin translocalizes between mitochondria and nucleus by
binding with the membrane lipid cardiolipin, tumor suppressor protein p53 and by the
differential phosphorylation. Prohibitin knockdown approach using small interfering
RNA (siRNA) demonstrate the elevated apoptotic signaling in the RPE under oxidative
stress and prohibitin is considered as an anti-apoptotic protein in the RPE (Sripathi et
al., 2011b). We also observed that the prohibitin expression was down regulated in the
diabetic retinopathy of rat, mouse and human RPE. On the other hand, prohibitin
expression was significantly upregulated in the aged retinas from rat, mouse and human.
Interestingly, our western blotting analysis showed that prohibitin levels increased in
12

both central (macula) and peripheral retinal regions, whereas the levels in the central
(macula) and peripheral regions of RPE were significantly decreased from the agerelated macular degeneration (AMD) donor eyes compared to the age matched controls.
To investigate the various functional properties of prohibitin and its relevant signaling
pathways, we aimed to understand the prohibitin’s potential binding partners and its
interacting

network

using

different

proteomic

approaches

such

as

co-

immunoprecipitation and MALDI-TOF mass spectrometry.
1.3 Nitric oxide (NO) regulated cytoskeleton reorganization and apoptosis in the
RPE under oxidative stress
Nitric oxide is a soluble atmospheric gas synthesized in different cell types and freely
diffusible across the cell membrane. Nitric oxide synthases (NOS) generates the nitric
oxide by the oxidation of guanidino nitrogen of its substrate L-arginine. The reaction
occurs in the presence of oxygen and NADPH with the formation of citrulline and
NADP as byproducts. Three different isoforms of NOS have been identified from
different genes with different localization, catalytic action, regulation and inhibition
(Marletta et al., 1988; Nathan, 1992). Nitric oxide is synthesized by three different
isoforms of nitric oxide syntheses (NOS) such as NOS-I (nNOS), NOS-II (iNOS) and
NOS-III (eNOS). nNOS is the first and predominating isoform mainly localized in the
neuronal tissue of central and peripheral nervous system, amacrine cells, bipolar cells
and photoreceptor (rod and cone) cells (Koch et al., 1994; Perez et al., 1995; Yamamoto
et al., 1993). Inducible nitric oxide synthase (iNOS) is a calcium dependent inducible
isoform generated by the immunological or inflammatory stimuli and the expression is
observed in the retinal Müller glial and retinal pigment epithelial cells after stimulation
with cytokines (IFN γ) and endotoxins (LPS) (Goureau et al., 1994). Recently, iNOS
expression was also identified in the retinal pericytes and capillary endothelial cells
(Chakravarthy et al., 1995). The calcium dependent eNOS isoform expresses in the
vascular endothelial cells and generates lower levels of nitric oxide. Endothelial nitric
oxide synthase (eNOS) expression was identified in endothelial cells of the blood
vessels located on the vitreous surface, between the nerve fiber layer (NFL), axons of
13

retinal ganglion cell layer (GCL), choroid and vascular endothelium of anterior segment
(Osborne et al., 1993). Various studies confirmed that nitric oxide acts as a neuro
modulator of synaptic transmission due to the modifications of electrical coupling in the
retinal horizontal cells (Miyachi et al., 1990). Nitric oxide generated from endothelial
and neuronal cells plays a major role in the regulation of cerebral blood flow (Estrada
and DeFelipe, 1998), synaptic transmission (Holscher, 1997). Rat RPE cells generates
higher levels of nitric oxide via inducible nitric oxide synthase (iNOS) in response to
endotoxin lipopolysaccharide (LPS), cytokines interferon-γ (IFN- γ),tumor necrosis
factor- α (TNF-α) and competitively inhibited with the treatment of nitric oxide
synthase inhibitor NG-Monomethyl-L-Arginine (L-NMMA) and cycloheximide
(Liversidge et al., 1994). Our studies reveal that RPE generates nitric oxide in
concentration and time dependent manner under light, oxidative stress and reoxygenation conditions. However, the physiological levels of nitric oxide produced in
the cells need to be detected to understand role of NO during RPE apoptosis under
pathological conditions.
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CHAPTER 2: MITOCHONDRIAL−NUCLEAR COMMUNICATION BY
PROHIBITIN SHUTTLING UNDER OXIDATIVE STRESS1
Srinivas R. Sripathi, Weilue He, Cameron L. Atkinson, Joseph J. Smith, Zhicong Liu,
Beth M. Elledge, and Wan Jin Jahng 1

1

The material included in this chapter was previously published in the journal
Biochemistry, 2011, 50 (39), pp 8342–8351DOI: 10.1021/bi2008933
Publication Date (Web): August 31, 2011Copyright © 2011 American Chemical Society
http://pubs.acs.org/doi/abs/10.1021/bi2008933
This study was supported by the Century II Equipment fund and the Research Excellence
Fund of Michigan Technological University.
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2.1 Abstract
Mitochondrial-nuclear communication is critical for maintaining mitochondrial
activity under stress conditions. Adaptation of the mitochondrial-nuclear network to
changes in the intracellular oxidation and reduction milieu is critical for the survival of
retinal and retinal pigment epithelial (RPE) cells, in relation to their high oxygen demand
and rapid metabolism. However, the generation and transmission of the mitochondrial
signal to the nucleus remain elusive. Previously, our in vivo study revealed that prohibitin
is up regulated in the retina, but down regulated in RPE cells in the aging and diabetic
model. In this study, the functional role of prohibitin in the retina and RPE cells was
examined using biochemical methods, including a lipid binding assay, two-dimensional
gel electrophoresis, immunocytochemistry, Western blotting, and a knockdown approach.
Protein depletion by siRNA characterized prohibitin as an anti-apoptotic molecule in
mitochondria, while the lipid binding assay demonstrated sub cellular communication
between mitochondria and the nucleus under oxidative stress. The changes in the
expression and localization of mitochondrial prohibitin triggered by reactive oxygen
species are crucial for mitochondrial integrity. We propose that prohibitin shuttles
between mitochondria and the nucleus as an anti-apoptotic molecule and a transcriptional
regulator in a stress environment in the retina and RPE cells.

16

2.2 Introduction
Mitochondrial-nuclear reciprocal signaling is the central question that needs to be
answered to understand the maintenance mechanism of appropriate mitochondrial
activities and functions in neurodegeneration. Disruptions of the mitochondrial-nuclear
network lead to accelerated aging and age-related diseases. Considering the significant
consequences of mitochondrial dysfunction in neurodegeneration and aging, it is crucial
to understand the molecular mechanisms of mitochondrial−nuclear communication by
protein shuttling (Cannino et al., 2007; Ryan and Hoogenraad, 2007). Cellular proteome
changes, including expression, localization, and modifications, to adapt an oxidative
environment are critical for the survival of retinal and retinal pigment epithelial (RPE)
cells, because of their high oxygen demand and upregulated metabolism, especially under
constant phototransduction. Oxidative stressors, including reactive oxygen species (ROS)
and a hypoxic environment, are serious risk factors in retinal degeneration, including agerelated macular degeneration (AMD) and diabetic retinopathy (DR). Understanding the
molecular mechanisms that mediate oxidative stress-induced proteome changes and
protein translocalization between mitochondria and nuclei may provide insight into
pathogenesis of retinal degeneration. Previously, our proteomic study demonstrated that
prohibitin is involved in oxidative stress signaling in the retina and RPE cells (Arnouk et
al., 2011b; Lee et al., 2010a). An in vivo study revealed that the aging process
upregulated prohibitin in the retina and decreased its level in RPE cells. Prohibitin was
first reported as an anti-proliferative protein or a tumor suppressor that binds to p53, E2F,
and Rb (McClung et al., 1989; Nijtmans et al., 2000a). It forms a high-molecular mass
complex with its isoform, prohibitin 2, in mitochondria (Steglich et al., 1999).
Localization of prohibitin has been controversial, possibly because of cell type and
extracellular stress, in being identified as mitochondrial, nuclear, or cell surface (RiveraMilla et al., 2006; Wang et al., 2002b). Prohibitin is ubiquitous in organisms ranging
from bacteria to plants to humans, but its function is not clearly understood at the
molecular level in each sub cellular organelle (McClung et al., 1995a). Prohibitin is
proposed to have roles as a cell cycle inhibitor, transcriptional regulator, inflammatory
modulator, plasma membrane receptor, and mitochondrial chaperone (Kolonin et al.,
17

2004a; Mishra et al., 2005; Nijtmans et al., 2000a; Patel et al., 2010; Sharma and Qadri,
2004a; Theiss et al., 2007b; Wang et al., 1999a; Wang et al., 1999b). Prohibitin plays a
role in apoptosis and aging by stabilizing newly synthesized respiratory enzymes;
however, its presence and function in the eye have never been elucidated (Bourges et al.,
2004; Nijtmans et al., 2002). In this study, we examined the antiapoptotic function and
the altered lipid interactions of prohibitin under oxidative stress. Translocalization of
prohibitin was observed between mitochondria and the nucleus as apoptotic signaling.
The changes in the expression and location of mitochondrial prohibitin triggered by redox
imbalance mediated by ROS suggest a critical role of prohibitin translocalization in the
maintenance of mitochondrial integrity. Here, we demonstrate that prohibitin is a new
dynamic regulator of mitochondrial and nuclear functions under stress in the retina and
RPE cells. Knockdown of prohibitin upregulated pro-apoptotic factors, including BAK
and caspases, and decreased the levels of anti-apoptotic molecules such as BCL-xL. The
significance of our study resides in our characterization of prohibitin as a mitochondrionnucleus shuttle to respond to ROS as an anti-apoptotic protein and also as a
transcriptional regulator by binding to p53 in the nucleus.
2.3 Materials and methods
2.3.1 ARPE-19 Cell Culture
ARPE-19 cells were transferred to tissue culture flasks (Nunc, Roskilde, Denmark)
containing Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) and 1% penicillin/ streptomycin and the flasks placed in a 5% CO2
incubator at 37 °C. After proliferation, cells were retrypsinized with a 0.1% trypsinEDTA solution (Sigma, St. Louis, MO) for 5 min at 37 °C. After centrifugation (125g for
7 min), cells were plated in 24- or 6-well plates (Nunc) at a density of 2 × 104 or 8 × 104
cells/well, respectively, and allowed to grow to confluence for 2−4 days. Eight- to
twelve-passage cells were used for experiments (Davis et al., 1995; Dunn et al., 1996).
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2.3.2 Oxidative Stress Treatment
ARPE-19 cells were incubated with fresh medium for 12 h before being treated.
Hydrogen peroxide (Mallinckrodt Inc.) was diluted (50, 100, 200, and 250 μM) in FBSfree medium. Cells were washed with PBS three times before being treated. Cells were
treated with H2O2 for 1, 2, 4, 6, 8, 12, and 24 h at 37 °C in a 5% CO2 incubator. Medium
was removed immediately after the treatment, and cells were washed with PBS and
harvested. Cells were lysed by RIPA buffer [0.5 M Tris-HCl (pH 7.4), 1.5 M NaCl, 2.5%
deoxycholic acid, 10% NP-40, and 10 mM EDTA (Millipore)] containing protease
inhibitor cocktail (Thermo Scientific) for sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS−PAGE) and Western blot analysis or immunocytochemistry.
Immunocytochemistry. ARPE-19 cells were incubated with the final concentration of 100
nM MitoTracker Orange CMTMRos (Molecular Probes, Carlsbad, CA) in FBS-free
culture medium for 30 min at 37 °C. After being washed in PBS, cells were fixed with
10% formaldehyde in PBS for 25 min at room temperature, and the membrane was
permeabilized with 0.2% Triton X-100 (Sigma) in PBS for 20 min. Cells were blocked
with complete medium containing 10% FBS and 0.05% Tween 20 (Sigma) for 1 h. Cells
were incubated with the anti-prohibitin antibody (1:500; Genemed Synthesis Inc., San
Antonio, TX) overnight at 4 °C. After being washed with PBS three times, cells were
incubated with Alexa Fluor 488- conjugated anti-rabbit IgG (1:700; Molecular Probes)
for 1 h at 25 °C. Finally, cells were mounted with VECTASHIELD Mounting Medium
with DAPI (4, 6-diamidino-2- phenylindole) to counterstain the nucleus. Images were
acquired using a Zeiss AxioVert 200 M Apo Tome fluorescent microscope with 63×
magnification.
2.3.3 Co-Immunoprecipitation
ARPE-19 cells were homogenized in lysis buffer [25 mM Tris, 120 mM NaCl, 0.3%
Triton X- 100, 15% glycerol, 2 mM PMSF, 10 mM EDTA, 0.2% sodium orthovanadate,
and protease inhibitor cocktail]. Cells were lysed by repeated freeze−thaw cycles and
sonication (3 × 5 min), followed by centrifugation at 13000g for 30 min. Proteins in
supernatant were purified by using control agarose resin, cross-linked by 4% bead
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agarose, to minimize nonspecific binding. The purified anti-prohibitin antibody was
immobilized with amino-linked protein A beads in the column with coupling buffer [0.5
mM sodium phosphate and 7.5 mM NaCl (pH 7.2)] and incubated with 3 μL of 5 M
sodium cyanoborohydride on a shaker at 25 °C for 2 h. Columns were washed with a
washing buffer [0.025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 1% NP-40, and 5%
glycerol (pH 7.4)]. Protein samples were incubated in the protein A−antibody column
with gentle mixing overnight at 4 °C. Columns were washed three times to remove
nonspecific binding proteins. Samples were equilibrated with Laemmli sample buffer
containing 100 mM DTT. Eluted proteins were separated by SDS−PAGE and visualized
by Western blot analysis using primary antibodies against prohibitin and p53. Protein
bands on the gel were visualized by silver staining (Bio-Rad, Hercules, CA).
2.3.4 Two-Dimensional SDS−PAGE
Protein samples were purified with the ReadyPrep 2-D Cleanup Kit (Bio-Rad) and
quantified using the BCA protein assay kit (Pierce, Rockford, IL). One hundred fifty
micrograms of protein was incubated in 200 μL of rehydration buffer (8 M urea, 2 M
thiourea, 2% CHAPS, and 50 mM DTT) and supplemented with 0.5% destreak IPG
buffer (pH 3−10) (GE Healthcare). Isoelectric focusing was conducted using 11 cm
immobiline dry strips (Bio-Rad) with linear pH 3 to 10 and pH 4 to 7 gradients. Strips
were rehydrated for 12 h at 20 °C. Proteins were separated with the Ettan IPGphor-3
instrument (GE Healthcare) using programmed voltage gradients at 20 °C for a total of
12 kVh (1 h at 500 V, 1 h at 1000 V, 2 h at 6000 V, and 40 min at 6000 V). The IPG
strips were reduced in equilibration buffer I [0.375 M Tris-HCl (pH 8.8), 6 M urea, 20%
glycerol, 2% SDS, and 50 mM DTT] for 20 min at 25 °C and alkylated for 20 min in
equilibration buffer II containing 150 mM iodoacetamide. The equilibrated strips were
placed on top of polyacrylamide gels (8−16%; Bio-Rad) and sealed with 1% agarose
buffer. Proteins were visualized by Coomassie staining using Imperial Protein Stain
(Pierce) and Western blot analysis.
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2.3.5 In-Gel Digestion and Mass Spectrometry
Selected protein spots from two-dimensional (2D) electrophoresis were excised from
gels. The gel pieces were destained twice with 200 μL of 50% acetonitrile (MeCN)/25
mM NH4HCO3 buffer (pH 8.0) at room temperature for 20 min, washed once with 200
μL of 100% MeCN, and vacuum-dried with a Speed Vac concentrator (Savant, Holbrook,
NY). The gel pieces were rehydrated with 13 ng/μL sequencing grade modified trypsin
(Promega, Madison, WI) in 25 mM NH4HCO3 and incubated at 37 °C overnight.
Peptides were subsequently extracted twice with 50 μL of a 50% MeCN/5% formic acid
mixture for 15 min at 37 °C. All extracts were combined and dried. The peptide extracts
were purified using the C18 ZipTip (Millipore). The peptides were eluted with 5 μL of a
75% MeCN/0.1% TFA mixture. The samples were analyzed by MALDI-TOF or tandem
ESI MS/MS as previously described (Arnouk et al., 2011b; Lee et al., 2010a; Lee et al.,
2010b; Lee et al., 2011; Zhang et al., 2010a).
2.3.6 Subcellular Fractionation
Bovine retinal tissues were separated and proteins isolated by the Cox and Emili
method, which uses different centrifugation in density gradients to generate nuclear,
mitochondrial and cytosolic protein components (Cox and Emili, 2006b). Cold PBS-pre
rinsed tissue was homogenized in homogenization buffer and centrifuged at 800g for 15
min. The pellet was resuspended for further isolation of nuclear proteins. The supernatant
was collected and centrifuged at 6000g for 15 min. The pellet was saved for mitochondria
and supernatant for cytosol-microsome separation. The crude nuclear fraction was
suspended in nuclear extraction buffer and separated by ultracentrifugation at 80000g for
35 min. To obtain mitochondrial membrane and matrix protein, the pellet was
resuspended in membrane extraction hypotonic lysis buffer centrifuged at 9000g for 30
min. Cytosolic proteins were obtained by spinning the supernatant for 1 h at 10,0000g.
2.3.7 SDS−PAGE and Western Blot Analysis
Protein quantification was conducted with the BCA protein assay kit (Pierce).
Samples were dissolved in Laemmli sample buffer [62.5 mM Tris-HCl (pH 6.8), 25%
glycerol, 2% SDS, and 0.01% bromophenol blue]. Proteins were resolved using 8 to 16%
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polyacrylamide precast gels (Bio-Rad), followed by electrotransfer onto the methanolactivated PVDF membrane, and blocked in 5% nonfat milk prepared in TTBS [0.1%
(v/v) Tween 20] for 1 h at 25 °C. The membranes were incubated with primary antibodies
at 4 °C overnight and subsequently incubated with corresponding horseradish peroxidaseconjugated secondary antibodies for 1 h at 25 °C. Proteins were visualized by using West
Pico Chemiluminescent Substrate (Pierce). Immunoreactive protein bands were acquired
using a LAS 4000 mini luminescent image analyzer and quantified using Quantity One
(Bio-Rad). Proteins in gels were stained with Imperial Protein stain and scanned using a
GS800 imaging densitometer (Bio-Rad).
2.3.8 Lipid−Protein Interaction Assay
Lipid strips were purchased from Echelon Biosciences or prepared using a
nitrocellulose membrane in the lab. For commercially available lipid strips, membranes
with a solvent blank control and 15 different lipids were initially blocked with
SuperBlock (Pierce) blocking buffer for 1 h at room temperature. To prepare our own
lipid strips, we spotted different amounts of lipids (100 pmol to 10 nmol), including
cardiolipin, cholesterol, and phosphatidylserine, onto the nitrocellulose membrane. The
membrane was air-dried for 1 h at room temperature. Crude proteins, fractionated
samples, or prohibitin partially purified by co-IP (1 μg/mL) from control ARPE-19 cells
or cells under oxidative stress (200 μM H2O2) was incubated with a nitrocellulose
membrane overnight. The membrane was washed three times with TTBS buffer [Trisbuffered saline with 0.1% (v/v) Tween 20], followed by incubation with the prohibitin
antibody (1:1000; Genemed Synthesis Inc.) overnight at 4 °C with gentle agitation. Blots
were washed with TTBS buffer and incubated with horseradishperoxidase conjugated
anti-rabbit secondary antibody (1:10000; Agrisera, Sweden) for 1 h at 25 °C. Strips were
developed with Super Signal West Pico Chemiluminescence Substrate (Pierce), and
proteins were visualized using a LAS 4000 mini luminescent image analyzer (Fuji).
2.3.9 siRNA Transfection
ARPE-19 cells were seeded in 24-well plates at a density of 6 × 104 cells/well with 0.1
mL of DMEM containing 10% FBS and 1% penicillin/streptomycin. Cells were
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incubated at 37 °C with 5% CO2. Cells were treated with 175 ng (final concentration of
23 nM) of siRNA (AAAGCCAGCTTCCTCGCATCT) against prohibitin (FlexiTube
siRNA) and random sequence control siRNA in 100 μL of culture medium without
serum. Transfection was conducted with HiPerFect transfection reagent (Qiagen,
Valencia, CA), and cells were harvested 48 h post-transfection. Proteins were assayed by
Western blot for detection of AIF (EMD Millipore), BCL-xL (sc-634; Santa Cruz
Biotechnology), caspase-9 (AB16969; EMD Millipore), BAK (ab32371; Abcam), and
actin (sc-47778; Santa Cruz Biotechnology). Protein localization and expression were
also analyzed by immunocytochemistry.
2.4 Results
2.4.1 Mitochondrial−Nuclear Trafficking of Prohibitin
Oxidative stress induced by hydrogen peroxide has been implicated in many ocular
diseases. RPE cells maintain a reducing environment within cells to balance the
production of reactive oxygen species and detoxification. Recently, we studied early
molecular signaling events during oxidative stress in the retina and RPE cells using a
comparative proteomics approach to identify altered protein levels (Arnouk et al., 2011b;
Chung et al., 2009b; Lee et al., 2010a; Lee et al., 2010c; Lee et al., 2011; Zhang et al.,
2010b). In RPE cells, one of the downregulated proteins under oxidative stress was
prohibitin. Changes in the prohibitin level in both diabetic and aging eyes suggest that it
may have an apoptosis-related function in RPE cells, especially under chronic stress and
pathophysiological conditions(Lee et al., 2010a).
First, we examined the cellular localization of prohibitin, which is a controversial
question. Translocalization of prohibitin in response to oxidative stress was examined
using immunocytochemistry. Subcellular organelles and prohibitin were visualized by
DAPI (nuclear DNA, blue, 369 and 460 nm for absorbance and emission, respectively),
MitoTracker Orange (mitochondria, red, 578 and 599 nm for absorbance and emission,
respectively), and Alexa Fluor 488 (prohibitin, green, 495 and 519 nm for absorbance and
emission, respectively), by taking three color fluorescent images every hour. A kinetic
assay confirmed that the signaling pathway was involved in the movement of prohibitin
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to the nucleus from mitochondria. Confluent ARPE-19 cells were treated with 200 μM
H2O2 for 24 h H2O2 treated cells showed nuclear trans-localization of prohibitin, whereas
untreated cells showed localization in mitochondria (Figure 1). After 8 h, prohibitin
showed an accumulation in the nucleus as compared to the control group. After 24 h,
more nuclear prohibitin was observed and much less co localized with mitochondria.

Figure 2.1 Translocalization of prohibitin under oxidative stress. ARPE-19 cells treated
with H2O2 (200 μM for 8 or 24 h) were analyzed by immunocytochemistry. Subcellular
organelles and prohibitin were visualized by DAPI (blue, nucleus), the prohibitin-specific
primary antibody, the Alexa Fluor 488-conjugated secondary antibody (green,
prohibitin), and MitoTracker Orange (red, mitochondria). Prohibitin was translocalized
from mitochondria to the nucleus under oxidative stress in a time-dependent manner. The
scale bar is 5 μm.
To examine prohibitin response in apoptosis signaling in detail, we then examined
changes in the protein expression level in vitro using ARPE-19 cells. We examined
changes in the prohibitin level under H2O2 in a time- and dose-dependent manner. Protein
analysis by SDS−PAGE and Western blotting demonstrated that prohibitin is down
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regulated under oxidative stress (200 μM H2O2 for 1−24 h) (Figure 2.2). Cells treated
with 200 μM H2O2 showed a 40% decrease in their level of prohibitin, but the levels
between treated groups after 24 h revealed no significant difference by t test, indicating
that a decreased level of prohibitin caused by oxidative stress is an acute process that
occurs within 2 h. Down regulation of prohibitin under stress conditions suggests that the
nuclear prohibitin may not be a newly synthesized protein as there was no increase in the
level of prohibitin for 24 h; the nuclear prohibitin might derive from mitochondria
because prohibitin was not colocalized with mitochondria after extended H2O2 treatment.

Figure 2.2 Downregulation of prohibitin under oxidative stress. ARPE-19 cells were
treated with H2O2. At specific time points, cells were harvested and proteins separated by
SDS−PAGE. Prohibitin was visualized by Western blotting. The level of prohibitin
decreased in all treated groups. ANOVA was used to demonstrate the differences among
groups. Statistical analysis showed that there is a significant difference among groups (P
< 0.01). Tukey’s Honestly Significant Difference (HSD) test was applied to find the
source of the difference. Results showed that control group was significantly different
from the treated groups (4 and 12 h, P < 0.01; 2, 8, and 24 h, P < 0.05). No significant
difference was found among treated groups.
To address the issue of the membrane binding property of prohibitin in RPE cells, we
investigated the effect of stress on protein solubility. First, we examined the correlation
between oxidative stress and soluble prohibitin and found that the ratio of soluble
prohibitin to membrane binding prohibitin decreased under oxidative stress. Prohibitin
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exists in both detergent resistant insoluble and soluble fractions and was separated by
SDS−PAGE using 8 to 16% gradient gels and the maximal running time. Membranebinding prohibitin showed slightly higher molecular mass when compared to that of
soluble prohibitin. As shown in panels A and B of Figure 3, the level of soluble prohibitin
from ARPE-19 cells decreased and the level of detergent-resistant, membrane-binding
insoluble prohibitin increased under stress conditions in 4 h. To compare insoluble and
soluble forms from subcellular organelles, we separated prohibitins from mitochondria
(M), cytosol (CYT), and whole cell lysate (WCL) by SDS−PAGE and visualized them by
Western blotting (Figure 3C). Soluble prohibitin from ARPE- 19 cells in the cytosolic
fraction (32 kDa) moved faster than membrane-bound mitochondrial and microsomal
prohibitin (34 kDa). The insoluble, detergent-resistant, membrane binding prohibitin
exhibited a slightly higher-molecular mass band compared to that of cytosolic, soluble
prohibitin. Prohibitins in whole cell lysate from both retinal and RPE cells showed two
bands as insoluble and soluble forms. It is possible that the membrane-binding and
soluble prohibitins may exist in different subcellular organelles, so we next examined the
subcellular localization of prohibitin.
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Figure 2.3 Detergent-resistant membrane prohibitin under oxidative stress. (A)
Detergent-resistant (insoluble) and soluble prohibitins were separated by SDS−PAGE
and visualized by Western blotting. Under oxidative stress (OS, 250 μM H2O2, 4 h),
detergent-resistant prohibitin was upregulated compared to the control. (B) Quantitative
analysis of insoluble and soluble prohibitin under oxidative stress. (C) Prohibitins from
bovine retinal cells and ARPE-19 cells were compared for the analysis of insoluble and
soluble forms. Mitochondrial prohibitin (M) moved slightly slower than the cytosolic
form (CYT). Whole cell lysate (WCL) from both bovine retinal cells and ARPE-19 cells
shows detergent-resistant insoluble and soluble forms of prohibitin.
2.4.2 Subcellular Localization of Prohibitin in the Retina and RPE Cells
Our previous experiments demonstrated that prohibitin may respond differently in the
retina and RPE cells under various oxidative stress conditions, including diabetes and
aging. To specify the location of prohibitin in the retina, we fractionated bovine retina
using serial centrifugation and specific detergents, including polyamines (Cox and Emili,
2006a). Via this method, proteins were separated by nuclear and mitochondrial extraction
buffer. Denatured and native gel electrophoresis and Western blotting of the subcellular
organelle showed that prohibitin is widely distributed in retina cells but centralized in
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mitochondria (Figure 2. 4). We used cytochome c, RNA polymerase II, and transketolase
as positive controls to show mitochondrial, nuclear, and cytosolic fractions, respectively.
Quantitative analysis showed that 60−80% of prohibitin in bovine retina was localized in
the mitochondrial membrane pellet (Figure 2.4, Mitochondria II) in bovine retina cells,
but the cytosol and nucleus (soluble I and membrane II) also contain a substantial amount
of prohibitin. Then we explored the prohibitin levels in different subcellular locations in
RPE cells. Our fractionation experiments using ARPE-19 cells showed that prohibitin has
a membrane-binding and soluble form. In ARPE-19 cells, prohibitin was mainly
expressed in mitochondria (60−80%) as determined by the Cox fractionation method
(Cox and Emili, 2006a).

Figure 2.4 Subcellular localization of prohibitin. Subcellular fractions were separated by
the Cox and Emili method. Proteins in the retina were fractionated on the basis of serial
centrifugations with extraction buffers and separated by SDS−PAGE. The prohibitin
concentration was quantitatively analyzed. Prohibitin in bovine retina was localized
mostly in mitochondria as a membrane-associated form (II, mitochondrial membrane)
rather than a soluble form (I, mitochondrial matrix). Prohibitin was also detected in the
nucleus. The relative amounts of prohibitin are presented as matrix (I) and membrane (II)
in mitochondria, nucleus (supernatant I and membrane-associated II), cytosol, and
microsome.
As prohibitin is widely spread in each subcellular fraction, we asked whether
different subcellular prohibitins have the same isoelectric point (pI). We used 2D
electrophoresis to isolate prohibitin from the fractionated subcellular proteome.
Mitochondrial, nuclear, cytosolic, and microsomal prohibitin were separated and
visualized by Coomassie staining and Western blotting (Figure 2.5). In the mitochondrial
fraction, prohibitin exhibited a molecular mass of 32 kDa and a pI of 5.6 as expected.
Prohibitin was more acidic in the nucleus, with a pI of 5.3, because of post-translational
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modifications such as phosphorylation. Cytosolic prohibitin showed very basic spots of
pI 6-7 and a higher molecular mass as shown in the box, representing potential
ubiquitination. As each subcellular prohibitin exhibited different pI values in 2D
electrophoresis, we examined potential post-translational modifications in bovine retinal
cells, including phosphorylation, using a different fractionation method (Cox and Emili,
2006a). Mitochondrial and nuclear fractions were further separated by matrix (Mito I and
Nucl I) versus membrane (Mito II and Nucl II) proteins. Prohibitin in the mitochondrial
matrix (Figure 2. 6, lane 1) and cytosol (Figure 2.6, lane 5) may exist as a putative
heterodimer at 75 kDa, whereas it showed multiple bands around 32 kDa in the nucleus
and cytosol, possibly because of phosphorylation or peripheral membrane interactions.
Proteins in each fraction were separated by electrophoresis, and prohibitin was visualized
by Western blotting using prohibitin and phosphatidylserine (p-Ser) antibodies. Only the
nuclear fraction exhibited phosphorylated prohibitin demonstrated by p-Ser Western blot
(Figure 2.6, lanes 9 and 10). Mitochondrial, cytosolic, and microsomal prohibitins did not
show phosphorylation. To confirm these data, we performed native gel electrophoresis
and produced the same result (Figure 2.6, lanes 9 and 10). Mass spectrometry (MALDITOF-TOF) analysis revealed that S101 and S151 sites are phosphorylated (data not
shown).
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Figure 2.5 2D SDS−PAGE analysis of prohibitin. Each fraction from bovine retinal cells
was separated by isoelectric focusing and gel electrophoresis. Prohibitin was visualized
by Western blotting. The nuclear fraction showed phosphorylated prohibitin as one acidic
spot at pI 5.3 shown by the arrow, whereas many modified prohibitin spots in the box
were detected in the cytosolic fraction.
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Figure 2.6 Phosphorylation of prohibitin in the nucleus. (A) Each fraction was further
separated by SDS−PAGE and phospho-Western blotting. Prohibitin in the mitochondrial
matrix (I) and cytosol shows a putative heterodimer at 75 kDa under denaturing
conditions, whereas nuclear prohibitin (supernatant I and membrane II) shows multiple
bands due to modifications and membrane association. Prohibitin in the nuclear fraction
was phosphorylated as shown by using the p-Ser antibody (lanes 9 and 10). (B) Proteins
were separated by native gel electrophoresis, and prohibitin was visualized by Western
blotting using the anti-prohibitin primary antibody and p-Ser antibody. Prohibitin in the
nucleus is phosphorylated as shown in lanes 9 and 10. Prohibitin may exist as a
heterodimer or oligomer as shown in lane 2 (mitochondrial membrane, 50, 150, and 750
kDa), lane 3 (nuclear supernatant, 150 kDa), lane 5 (cytosol, 75 and 150 kDa), and lane 6
(microsome, 150 kDa).

31

2.4.3 Prohibitin Binds Cardiolipin under Oxidative Stress
We next asked whether prohibitin localization could be controlled by membrane lipid
binding. Considering mitochondrion- specific lipid composition, we speculated that the
localization and trafficking of prohibitin might be determined by a mitochondrionspecific lipid such as cardiolipin. Prohibitin in the bovine retina binds with cardiolipin, a
major mitochondrial phospholipid (Figure2.7A). The lipid interaction assay demonstrated
that mitochondrial prohibitin from bovine retina has a strong affinity at relatively low
cardiolipin concentrations (10−15 μg, 6−10 nmol), whereas nuclear prohibitin showed a
weaker affinity for cardiolipin (Figure 2.7). However, prohibitins in RPE cells showed
different lipid interactions under oxidative stress when we examined prohibitin using
ARPE-19 cells. Under normal conditions, prohibitin from ARPE-19 cells demonstrated a
strong interaction with phosphatidylinositol 3,4,5-triphosphate (PIP3)

but not with

cardiolipin (Figure 2.8). The lipid binding affinity changed dramatically under oxidative
stress induced by H2O2 (200 μM). Prohibitin under stress showed a strong affinity for
cardiolipin as shown in Figure 2.8. This observation led us to conclude that prohibitin has
an affinity for negatively charged phospholipids, especially cardiolipin. Lipid analysis by
mass spectrometry demonstrated that the cardiolipin concentration decreased 20−70%
under 200 μM H2O2 (data not shown).
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Figure 2.7 Prohibitin−cardiolipin interactions. (A) Prohibitin in the nucleus and
mitochondria from bovine retina showed different cardiolipin affinities depending on the
cardiolipin concentration. (B) Quantitative analysis of prohibitin−cardiolipin binding.
Data for mitochondrial prohibitin (■) and nuclear prohibitin (●) are shown. The Y-axis
represents the relative binding affinity and the X axis the cardiolipin concentration.
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Figure 2.8 Fractionated or IP-purified proteins were incubated with the nitrocellulose
membrane coated with various lipids. The membrane was incubated with
immunoprecipitated prohibitin, and the lipid- prohibitin interaction was visualized by
Western blotting. Prohibitin-lipid binding was changed under oxidative stress (200 μM
H2O2). Under normal conditions, prohibitin interacts with phosphatidylinositol
phosphates (PIP3), whereas under oxidative stress, prohibitin binds with cardiolipin.
2.4.4 Anti-Apoptotic Prohibitin Function in Mitochondria
We performed a loss of function study with prohibitin-specific small interfering RNA
(siRNA), resulting in an increase in the level of apoptotic signaling at decreased
prohibitin levels (Figure 2.9). We tested two siRNA constructs that inhibit prohibitin
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expression against a control siRNA that has a random sequence. A solvent vehicle was
used as a negative control. We chose conditions under which the levels of prohibitin
expression were reduced by 80−90% when compared to the random sequence control.
We examined whether anti-apoptotic molecules such as BCL-xL and proapoptotic
molecules that include apoptosis inducing factor (AIF), caspases, and BCL-2 homologous
antagonist/killer (BAK) are also activated as essential markers in apoptosis (Figure 2.9).
The activation of AIF and caspase-9 cleavage, the upstream regulators in apoptosis,
showed early apoptotic signaling under prohibitin knockdown conditions. However, the
level of anti-apoptotic BCL-xL decreased when prohibitin was downregulated. Further,
we investigated whether prohibitin knockdown cleaves poly(ADP ribose) polymerase
(PARP) as a pro-apoptotic marker. PARP cleavage is an early marker of caspase
activation. Transfection of siRNA of prohibitin into ARPE-19 cells resulted in an
increased level of cleavage of PARP, which represents the fact that an apoptotic signal is
induced when prohibitin is downregulated (data not shown). Our results demonstrate that
knockdown of prohibitin increases the strength of apoptotic signaling. These observations
suggest that prohibitin may act as an anti-apoptotic protein in mitochondria by forming a
functional complex with apoptotic proteins. The prohibitin concentration is inversely
correlated with the initiation of apoptosis. Then we examined whether a decreased level
of prohibitin disrupts the filamentous reticular network of mitochondria and results in
fragmented mitochondria. Immunocytochemical analysis showed that prohibitin
knockdown led to accumulation of fragmented mitochondria as shown in Figure 2.9B.
Fragmented mitochondria imply that the fusion of mitochondrial membranes is impaired
when the prohibitin concentration is decreased.
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Figure 2.9 Anti-apoptotic prohibitin shown by knockdown analysis. (A) ARPE-19 cells
were transfected by siRNA and random sequence. The level of anti-apoptotic BCL-xL
increased when prohibitin was downregulated. Pro-apoptotic proteins, including AIF,
caspase-9, and BAK, were upregulated under prohibitin knockdown conditions. (B)
ARPE-19 cells under siRNA or random sequence were analyzed by
immunocytochemistry. Prohibitin, mitochondria, and the nucleus were visualized by
Alexa Fluor 488 (green), MitoTracker Orange (red), and DAPI (blue), respectively.
When prohibitin was downregulated by siRNA, the mitochondrial structure was
disrupted, and mitochondrial prohibitin was moved to the nuclear membrane.
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2.4.5 Prohibitin Function in the Nucleus
To address a putative functional role of prohibitin in the nucleus, protein- protein
interaction was examined. Immunoprecipitation of prohibitin demonstrated that
prohibitin is involved in direct regulation of transcription through p53 binding. The
prohibitin−protein binding assay using the anti-prohibitin primary antibody, followed by
SDS−PAGE, and mass spectrometry demonstrated that prohibitin has interactions with
transcription factors that include tumor suppressor p53. A Western blot of
immunoprecipitated fractions confirmed prohibitin-p53 interaction as shown in Figure
2.10. To test oxidized cardiolipin-dependent translocalization, we examined a known
cardiolipin antioxidant etoposide. Etoposide is an antitumor drug that acts as a
topoisomerase II inhibitor and is used to block cardiolipin oxidation and prohibitin
translocalization. Treatment for 1 h induced translocalization of prohibitin from the
nucleus to the cytosol.

Figure 2.10 Binding of prohibitin to p53. Immunoprecipitation using the prohibitin
antibody demonstrated the interaction between prohibitin and p53. The purified antiprohibitin antibody was immobilized with amino-linked protein A and washed. Protein
samples were incubated in the protein A−antibody column with gentle mixing overnight
at 4 °C. Columns were washed three times to remove nonspecific binding proteins.
Eluted fractions were separated by SDS−PAGE and visualized by western blotting using
primary antibodies against prohibitin and p53.
2.5 Discussion
In this study, we demonstrate that prohibitin is translocalized from mitochondria to the
nucleus as a mitochondrial response to oxidative stress in vitro. Previously, we
37

investigated oxidative stress-induced proteome changes in RPE cells using the
differential gel electrophoresis (DIGE) technique to identify early biomarkers of eye
diseases (Lee et al., 2010a; Ryan and Hoogenraad, 2007). We were seeking a novel
protein that shuttles between mitochondria and the nucleus as the initiation step in retinal
pathogenesis. We found that prohibitin changes its subcellular location under stress
conditions. In this study, dynamic translocalization of prohibitin was examined by
subcellular fractionation, immunocytochemistry, a lipid binding assay, and a knockdown
approach. This study challenges a question of mitochondrial−nuclear (MT-NU)
communication by protein translocalization through the lipid interaction change
mechanism. Knockdown and immunoprecipitation studies suggest that trafficking
prohibitin may have a dual function as an anti-apoptotic molecule that maintains
mitochondrial structure and as a transcriptional activator that interacts with p53 in the
nucleus. We tested the hypothesis that a lipid binding property of prohibitin may
determine mitochondrial localization. As prohibitins are expected to be dynamically
translocated within retinal and RPE cells, there is an essential need for a time-dependent
assay of cellular prohibitin movement. Under oxidative stress, the level of cardiolipin
decreased and the level of cardiolipin-prohibitin interactions increased. At relatively low
cardiolipin concentrations (<6−10 nmol), mitochondrial prohibitin competes with nuclear
prohibitin for cardiolipin binding. We examined whether levels of prohibitin in
mitochondria and the nucleus are altered by oxidative stress. We found that the level of
prohibitin initially decreased by mild oxidative stress with H2O2 treatment especially at
the IC50 concentration (Chung et al., 2009b; Lee et al., 2010a). Translocalization of
prohibitin under stress conditions led us to investigate post-transcriptional regulation. A
proteomics approach using SDS−PAGE and phosphor-Western blotting demonstrated
that soluble nuclear prohibitin is phosphorylated. Gel electrophoresis under denatured or
native conditions showed that prohibitin may exist as a heterodimer, soluble, membraneassociated, and post-translationally modified form in different subcellular organelles.
Upregulation of pro-apoptotic molecules and down regulation of anti-apoptotic proteins
under prohibitin depletion by siRNA suggest an anti-apoptotic response of prohibitin
depending on the prohibitin levels. To maintain mitochondrial integrity, nuclear and
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mitochondrial genes should communicate with each other, especially under stress
conditions that include hypoxia, abnormal temperature, nutrient deficiency, and aging.
Our results suggest that prohibitin may fulfill dual roles as a phospholipid scaffold switch
and an MT−NU shuttle under stress conditions in the retina and RPE cells. Coordinated
prohibitin−lipid interactions, including cardiolipin and PIP3, support the phospholipid
scaffold switch mechanism hypothesis (Osman et al., 2009; van Gestel et al., 2010).
Cardiolipin, a negatively charged diphosphatidylglycerol-derived phospholipid, is mainly
localized in mitochondria and plays a significant role in maintaining mitochondrial
membrane function and structure. The level of cardiolipin decreases with aging and is
involved in the upregulation of mitochondrially derived reactive oxygen species.
Considering cardiolipin’s role in mitochondria, it is reasonable to speculate that
cardiolipin composition may affect targeted trafficking of mitochondrial proteins,
especially under oxidative stress. The age-related decrease in the level of cardiolipin is
correlated with increased cholesterol: phospholipid ratio (Shigenaga et al., 1994a).
Cholesterol depletion using β-cyclodextrin and simvastatin upregulated prohibitin
expression, and cholesterol treatment decreased the level of prohibitin in ARPE-19 cells
(data

not

shown).

Post-translational

modifications

that

include

hydrophobic

palmitoylation and negatively charged phosphorylation may affect membrane binding
and translocalization in subcellular organelles (Ande and Mishra, 2010; Lee et al., 2010b;
Morrow et al., 2002; Xue et al., 2004). Consistent with our results, recent studies using
proapoptotic peptide targeting prohibitin demonstrated that prohibitin might be connected
to upregulation of lipid turnover and an increased metabolic rate (Kolonin et al., 2004a).
Changes in cellular metabolism are a central hallmark in the aging process in the retina
and RPE cells. When apoptosis was induced by prohibitin-peptide binding, it was shown
that the levels of lipid metabolism, energy expenditure, oxygen consumption, and heat
generation increased. Using Caenorhabditis elegans as a model system, it was reported
that prohibitin depletion affected ATP levels, lipid content, and mitochondrial
proliferation in an age-specific manner (Artal-Sanz and Tavernarakis, 2009b). Our results
support the hypothesis that prohibitin may have a similar role in modulating
mitochondrial structure by binding cardiolipin to maintain mitochondrial integrity under
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stress conditions. This study also demonstrated that prohibitin expression levels may
determine the mitochondrial morphology and distribution as shown by the knockdown
approach. Recent studies examined the versatile functions of prohibitin as a drug
resistance mediator, plasma membrane receptor, obesity regulator, and cancer target
(Artal-Sanz and Tavernarakis, 2009b; Gregory-Bass et al., 2008; Ko et al., 2010; Nuell et
al., 1991; Patel et al., 2010; Terashima et al., 1994; Zubovych et al., 2006). A metabolic
switch mechanism of prohibitin was shown by pyruvate carboxylase inhibition and PIP3
binding (Ande and Mishra, 2009). Prohibitin may modulate glucose and fatty acid
oxidation by balancing between oxidative phosphorylation and anaerobic glycolysis
under rapid proliferation, which are associated with malignant transformation (Mishra et
al., 2006). Down regulation of prohibitin may activate a retrograde communication that
induces mitochondrial proliferation and an increased level of reactive oxygen species
(ROS) (Artal-Sanz and Tavernarakis, 2009a; Artal-Sanz et al., 2003; Coates et al., 1997;
Fusaro et al., 2003b; Ikonen et al., 1995; Rajalingam et al., 2005; Sanchez-Quiles et al.,
2010; Shigenaga et al., 1994b). A functional role for prohibitin in the nucleus was
suggested as a transcriptional regulator by observation of its interactions with p53, E2F,
and Rb (Fusaro et al., 2003a). In cancer cells, prohibitin is localized in the nuclear matrix
(Shi et al., 2009). Cholesterol-induced downregulation of prohibitin was shown as a
regulator of cell cycle transit in the nucleus (Dong et al., 2010; Sanchez-Quiles et al.,
2010). Our previous study suggested that NF-κB was translocated into the nucleus under
oxidative stress, and protein translocalization may act as a cell survival mechanism under
stress conditions (Lee et al., 2010a). Nuclear tumor suppressor p53 also translocalized
into mitochondria under apoptotic conditions. The coordinated translocalization of
prohibitin may determine cell viability and the apoptotic cell population in the retina and
RPE cells. Prohibitin under oxidative stress and altered lipid environments may regulate
the cell survival or death pathway by changing protein−lipid interactions. In the
beginning of retinal degeneration, prohibitin may act as anti-apoptotic molecules as the
default function in mitochondria, whereas it may become a transcriptional regulator under
prolonged or repeated stress conditions. This dual function of prohibitin might be the
essential mechanism for controlling apoptotic signaling as a cell fate determinant from
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uncontrolled proliferation as suggested by the conserved gene evolution in an oxidative
environment (Di et al., 2010).
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3.1 Abstract
Light is a risk factor for various eye diseases, including age-related macular
degeneration (AMD) and retinitis pigmentosa (RP). We aim to understand how
cytoskeletal proteins in the retinal pigment epithelium (RPE) respond to oxidative stress
and how these responses affect apoptotic signaling. Previously, proteomic analysis
revealed that the expression levels of vimentin and serine/threonine protein phosphatase
2A (PP2A) are significantly increased when mice are exposed under continuous light for
7 days compared to a condition of 12h light/dark cycling exposure using retina
degeneration 1 (rd1) model. When melatonin is administered to animals while they are
exposed to continuous light, the levels of vimentin and PP2A return to a normal level.
Vimentin is a substrate of PP2A that directly binds vimentin and dephosphorylates it. The
current study shows that upregulation of PP2Ac (catalytic subunit) phosphorylation
negatively correlates with vimentin phosphorylation under stress condition. Stabilization
of vimentin appears to be achieved by decreased PP2Ac phosphorylation by nitric oxide
induction. We tested our hypothesis that site-specific modifications of PP2Ac may drive
cytoskeletal reorganization by vimentin dephosphorylation through nitric oxide signaling.
We speculate that nitric oxide determines protein nitration under stress conditions. Our
results demonstrate that PP2A and vimentin are modulated by nitric oxide as a key
element involved in cytoskeletal signaling. The current study suggests that external stress
enhances nitric oxide to regulate PP2Ac and vimentin phosphorylation, thereby
stabilizing or destabilizing vimentin. Phosphorylation may result in depolymerization of
vimentin, leading to nonfilamentous particle formation. We propose that a stabilized
vimentin might act as an anti-apoptotic molecule when cells are under oxidative stress.
3.2 Introduction
Intense light kills retinal and RPE cells through irreversible apoptotic reactions (Adrian et
al., 1977; Grimm et al., 2002; Grimm et al., 2000; Noell et al., 1966; Young, 1988).
Paradoxically light may protect the retina and RPE by controlling expression of antiapoptotic and anti-oxidative molecules, including erythropoietin, thioredoxin (THR), and
heme oxygenase-1 (HO-1) (Grimm et al., 2002). Excess light may trigger circadian43

dependent pathologic signals and oxidative stress by changing expression of proteases or
proteins in the visual cycle that include caspases, rhodopsin, cellular retinaldehyde
binding protein (CRALBP), and RPE65 (Chung et al., 2009b; Lee et al., 2010c; Zhang et
al., 2010b). The mechanism of oxidative stress-induced apoptosis still remains elusive,
but our previous proteomics approach implies that the protein expression profile,
including BCL-xL, prohibitin, and vimentin, might be involved in the initiation of
apoptosis as a positive or negative signal (Arnouk et al., 2011b; Chung et al., 2009b;
Zhang et al., 2010b). Our studies suggest that the balance between anti- and pro-apoptotic
proteins as well as the balance between oxidative stress and anti-oxidative shield may
determine the cell fate based on external light/dark cycle environment. Apoptotic cell
death induced by intense or constant light in the retina and RPE may lead to major
diseases that cause blindness, including AMD and RP (Grimm et al., 2002; Grimm et al.,
2000). Retinal and RPE cells have chromophores, including rhodopsin, peropsin, and
retinal G protein receptor (RGR) that contain 11-cis-retinoid that can be isomerized by
photons. Rhodopsin is a mediator of intense light-induced apoptosis and the activation of
the transcription factor AP-1 complex (c-Fos/Jun) acts as a central downstream pathway
for light-induced apoptosis. However, the mechanism by which light causes
morphological alterations that initiate the death signal is elusive. Lack of such knowledge
is an important issue, because without it, acquiring the ability to modulate cellular
protection is highly unlikely. Thus there is an urgent need for the understanding of the
molecular and biochemical mechanisms involved in light-induced cytoskeletal changes.
Our previous studies suggest that post-translational nitration or phosphorylation may
regulate cytoskeletal reorganization and protein trafficking under oxidative stress
(Arnouk et al., 2011b; Chung et al., 2009b; Lee et al., 2010c; Sripathi et al., 2011c; Zhang
et al., 2010b). Nitric oxide (NO) is a highly reactive free-radical gas that is involved in
the expression of erythropoietin receptors (EPOR) in neurons from mouse brains (Chen et
al., 2010; Genc et al., 2001). Recent studies suggest that NO plays a specific role in the
protective pathway; however, it is nearly impossible to establish optimal levels of NO
efficacy using current techniques. Clearly defining how much NO is needed and for what
duration it is produced to induce up-regulation of protein phosphorylation is critical
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because excess levels of NO is toxic and will lead to tissue damage and cell death
(Karnovsky, 1985; Sortino, 2010; Sugimoto et al., 2000). In the current study, NO
produced by cells was detected continuously in situ using a chemiluminescence reaction
between NO and ozone. We aimed to establish therapeutic levels of NO that induces upregulation of protecting molecules. The objective of our study is to answer the question
whether NO prevents retinal degeneration by inducing or inhibiting phosphorylation
signaling of target proteins. To attain the objective of this aim, we tested the working
hypothesis that NO may have a dual role as a physiological neuroprotectant and a
pathological cytotoxic compound depending on concentration and location. The levels of
NO produced by RPE cells were directly measured under different levels of light or
oxidative stimulation. We have quantitatively established what level and duration of NO
accounts for its protective properties and at what level NO becomes pathological in RPE
cell death. Our results suggest that NO is generated in RPE cells under various oxidative
stress conditions in a time-dependent manner. Appropriate levels of NO control
phosphorylation of vimentin and PP2A in the RPE that may lead to regulate stressdependent apoptotic pathways.
3.3 Material and methods
3.3.1 ARPE-19 Cell Culture
Human retinal pigment epithelial cells (ARPE-19) were obtained from American Type
Culture Collection (Manassas, VA). Cells were cultured in 25 cm2 flask (Corning, St.
Louis, MO) or 56.7 cm2 dishes (Nunc, Naperville, IL) containing Dulbecco’s modified
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Sigma, St. Louis,
MO) and 1% penicillin/ streptomycin (Hyclone, Logan, UT). Cells were maintained in
humidified 5% CO2 incubator at 37 °C.
3.3.2 Light, oxidative stress, reoxygenation, and LPS treatment
Confluent ARPE-19 cells were exposed to bright fluorescent light (7000 lux), tert-butyl
hydroperoxide (200 μM), reoxygenation (2 hrs hypoxic condition by N2 then 21% O2)
and LPS (5-10 μg/mL) in serum free medium for different time intervals in CO2 incubator.
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Cells grown in 25 cm2 flasks were used to measure NO release in situ. Cells were
harvested to extract total proteins using ice cold 1X RIPA lysis buffer [0.5 M Tris-HCl
(pH 7.4), 1.5 M NaCl, 2.5% deoxycholic acid, 10% NP-40, and 10 mM EDTA (Millipore,
Darmstadt, Germany)] containing protease inhibitor cocktail (Pierce, Rockford, IL). Cell
lysates were centrifuged at 10,000 x g for 30 min at 4 °C to pellet cell debris. Proteins
were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS−PAGE), followed by Western blotting analysis.
3.3.3 Direct NO measurement
NO release from ARPE-19 cells was measured via chemiluminescence detection with
Sievers 280i Nitric Oxide Analyzer (GE Instruments, Boulder, CO) using 200 mL/min
ambient air with added 5% CO2 sweep gas. NO analyzer was equilibrated with 5% CO2
incubator for 30 minutes before the experiment. Prior to NO analysis, the instrument was
calibrated three times using NO (45 PPM) and air by passing through a Sievers NO zero
filters, followed by zero calibration. Confluent cells grown in T25 flask under oxidative
environment (light; exposed to 7000 lux of fluorescent light, oxidative stress; treated with
200 μM of t-butyl hydroperoxide, reoxygenation; 21% O2 added at 2 hrs, LPS; treated
with 5μg/mL of LPS) were directly connected to Nitric Oxide Analyzer using custom
made adaptor. The amount of released NO is measured in PPB (parts per billion) and is
converted to mole per surface area by a calibration factor (nmole·cm-2·min-1) then
represented by graphs using MATLAB software. To determine intracellular NO
formation using a fluorescent molecule, cells were incubated in media containing 4,5diaminofluorescein-2-diacetate (DAF-2DA, 5μM, Sigma) for 15 min after stress
treatment (12,000 lux light, 24 hrs). After washing three times with PBS, cells were fixed
with 2% glutaraldehyde for 3 min. Images were acquired using Zeiss Axiovert 200M Apo
Tome fluorescent microscope with 63 X magnifications.
3.3.4 SDS-PAGE and Western Blot analysis
Proteins were quantified using BCA protein assay kit (Pierce) based on the
manufacturer’s protocol by plotting BSA standard curve. Samples were dissolved in 4X
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Laemmli sample buffer (240 mM Tris pH 6.8, 8% SDS, 40% glycerol, 0.4%
bromophenol blue, 10% β- mercaptoethanol), heated at 90°C for 10 min. Proteins were
resolved using 10% or 8-16% gradient polyacrylamide precast gels (Bio-Rad), followed
by electrotransfer on to the methanol activated PVDF membrane (Bio-Rad) via semidry
transfer by applying 20V for 30 min. Non-specific proteins were blocked for 1 hr at 4°C
with 5% nonfat dry milk (Bio-Rad) prepared in TBS with 0.1% (v/v) Tween-20.
Membranes were probed with primary antibodies (Santa Cruz Biotechnology Inc, CA),
including iNOS (sc-651; 1:100), Nitrotyrosine (sc-32731; 1:25), p-vimentin (sc-16673;
1:500), p-PP2Ac (sc-12615; 1:500), Bcl-xL (sc-634; 1:500) and β-actin (sc-47778;
1:1000) at 4 °C for overnight and subsequently incubated with corresponding horse
radishperoxidase conjugated secondary antibodies for 2 h at room temperature.
Membranes were developed with West Pico Chemiluminescent Substrate (Pierce) for 2
min and immunoreactive protein bands were visualized using a LAS 4000 mini
luminescent image analyzer (GE, Piscataway, NJ). Bands were quantified based on pixel
size/intensity/area using Quantity One software (Bio-Rad) and graphs were plotted based
on relative intensity of bands using GraphPad Prism software.
3.3.5 Immunocytochemistry
ARPE-19 cells were seeded on sterile glass cover slips placed in 6 well plate (Nunc, 10
cm2 per well) with serum containing DMEM/F12 media supplemented with

1%

penicillin–streptomycin (Hyclone) 5% CO2 incubator at 37 °C. Cells were treated with
200 μM of tert-butyl hydroperoxide for 36 or 48 h to induce oxidative stress. Cells were
fixed with 10% formaldehyde in PBS for 30 min at RT. After fixation, cells were
incubated in 0.2% Triton X-100 (Sigma) for 25 min to permeabilize cell membrane and
blocked with complete media containing 10% FBS and 0.05% Tween-20 (Sigma) for 1 hr
and probed with anti-iNOS, anti-vimentin antibody (1:100; Santa Cruz) for overnight at
4 °C. Subsequently, cells were stained with Alexa Fluor 488- conjugated anti-rabbit IgG
(1:700, Molecular Probes) for 2 hrs at RT. Finally, immunostained samples were mounted
using Vectashield (Vector Laboratories, Burlingame, CA) mounting medium containing
DAPI (4, 6-diamidino-2-phenylindole) to counterstain the nucleus. Images were captured
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using fluorescent microscope (Zeiss AxioVert 200 M Apo Tome) with 20X magnification.
3.3.6 Scanning Electron Microscopy (SEM)
ARPE-19 cells were cultured on coverslips in 6 well plate (Nunc, 10 cm2 per well). Cells
were treated with 100 μM of H2O2 in serum free media for 2 hrs to induce oxidative
stress. Sample preparation protocol was followed as previously reported(Karnovsky,
1985). After brief wash with PBS, cells were immersed immediately into fixative solution
containing 3% paraformaldehyde and 0.1% glutaraldehyde in phosphate buffer (pH 7.1)
at RT for 1 hr. Samples were removed from the fixing solution and washed three times
with PBS and then post fixed in 1% osmium tetroxide in 0.2M phosphate buffer. After
three additional brief washings in distilled H2O, cells were dehydrate in a graded EtOHH2O series and then critical-point-dried in a CO2 chamber. Cells were coated with a 10
nm layer of platinum-palladium alloy in a vacuum evaporator to examine in the scanning
electron microscope (JEOL JSM-6400) at 4000X magnification.
3.4 Results
3.4.1 NO Production in the RPE under Oxidative Stress
To address the issue of the protective and pathological roles of NO in neurodegeneration,
we directly measured NO produced by RPE cells exposed to different stresses. First we
asked how much NO is generated and what duration it is produced under various
environmental stimuli. We aimed to establish therapeutic or cytotoxic levels of NO that
induce up-or down-regulation of phosphorylation signaling of vimentin and PP2A. NO
produced by RPE cells were determined in situ after exposure to each of following: dark,
light, oxidative stress, reoxygenation, and lipopolysaccharide (LPS) as shown in Figure
3.1A. Cells exposed to dark conditions did not show any detectable increase of NO
levels. Cells treated with light (7000 lux) showed an increase in NO concentration after
19 hrs of exposure. Cells treated with 200 μM tert-butyl hydroperoxide (t-BuOOH,
oxidative stress) showed an increase in NO concentration at 16, 18, and 20 hrs. Based
on the observation of the increased levels of NO, oxidative stress and light play a positive
regulatory role in the production of NO by ARPE-19 cells. NO generation positively
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correlates with our Western blotting analysis of iNOS under light and oxidative stress.
Cells treated with reoxygenation after hypoxic conditions (nitrogen stream for 2 hours)
before being exposed back to normoxia (21% O2) showed the greatest elevation in NO
production, immediately after reoxygenation at 2 hrs and remained active for 20 hrs.
This data suggests that O2 is the limiting factor for NO synthesis in RPE cells.
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Figure 3.1 A. Dark, light, oxidative stress, reoxygenation, and LPS induced NO
production in vitro. Confluent ARPE-19 cells cultured in T-25 flasks were incubated
under intense light (7000 lux), oxidative stress (200 μM t-BuOOH), reoxygenation
(hypoxia by N2 flow for 2 hrs then 21% O2) and lipopolysaccharide (5 μg/mL) in
humidified 5% CO2 chamber. Released NO from cells was detected each second for total
24 hrs using Nitric Oxide Analyzer 280i. NO released from cells reacts with ozone to
produce NO2 and a photon as a chemiluminescence signal which is proportional to NO
concentration. X-axis represents time (hrs) and Y-axis represents concentration in parts
per billion (PPB). B. Quantitative analysis of NO released (PPB) and NO surface flux
(nmole/(min*cm^2)) under intense light, oxidative stress, reoxygenation, and
lipopolysaccharide condition. C. Light induced NO detection by 4, 5-diaminofluorescein
diacetate (DAF-2DA). ARPE-19 cells were treated with the dark or intense light (12,000
lux) conditions. Cells were incubated with 5 μM 4, 5 diaminofluorescein diacetate (DAF2DA) (excitation at 470 to 490 nm and emission at 515 nm, green) for 15 min followed
by fixation with 2% glutaraldehyde to detect NO levels under light induced stress.
As a positive control for NO production, cells were treated with LPS (5μg/mL),
which also stimulated secretion of NO. NO secretion occurred at 12, 17, 19.5, and 23
hours. This was the most significant increase in NO secretion for any of the conditions
tested. A quantitative analysis of NO release is shown in Table 1.1. Light induced
intracellular NO in the RPE was detected using 4, 5-diaminofluorescein 2- diacetate
(DAF-2DA) as shown in Figure 3.1B. Detection of intracellular NO in living cells using
DAF-2DA is a recently developed method in combination with aldehyde fixation. Our
fluorescent analysis illustrated that RPE cells exposed to intense light (12,000 lux)
generated higher levels of intracellular NO compared to dark control. The control in the
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dark did not show any detectable fluorescence, provides the direct evidence that RPE
cells under intense light generate NO.
3.4.2 Treatment with LPS, tert-butyl hydroperoxide (t-BuOOH) and light
upregulates inducible nitric oxide synthase (iNOS) in the RPE
Since NO generation is controlled by iNOS, expression changes of iNOS in response to
external stimuli were analyzed by Western blotting. As shown in Figure 3.2A, LPS,
oxidative stress, and light treatment significantly upregulated iNOS expression in RPE
cells in concentration or time-dependent manner. Levels of iNOS expression are also
consistent with NO production in RPE cells. iNOS is responsible for the conversion of
L-arginine to NO and citrulline in the cell. ARPE-19 cells were treated with light (7,000
lux) for 12 and 18 hours, as well as a control that had no light exposure (Figure 3.2B).
Light exposed cells had higher levels of iNOS expression compared to time 0 controls,
with 18 hrs having a higher concentration than 12 hrs and the control showed no visible
band of iNOS. Another group of ARPE-19 cells were treated with oxidative stress in the
form of 200 µM t-BuOOH, or LPS at either 5 or 10 µg/mL. A control sample showed no
iNOS at 130 kDa, while the samples treated with oxidative stress and LPS showed iNOS,
suggesting an upregulation of iNOS due to these conditions. LPS exposure caused the
most significant increase in iNOS upregulation.
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Figure 3.2 Expression of inducible nitric oxide synthase (iNOS) under LPS, oxidative
stress and light treatment. ARPE-19 cells were treated with LPS (5 or 10 μg/mL for 24
hrs), tert-butyl hydroperoxide (200 μM for 24 hrs), and intense light (1000 lux for 24
hrs). Cells were harvested, lysed and proteins were separated by SDS-PAGE. Expression
of iNOS (130 kDa) was visualized by western blotting using rabbit polyclonal anti-iNOS
antibody. A low molecular weight non-specific band at 65 kDa was used as a loading
control. A. Oxidative stress induced expression of iNOS in RPE cells. B. Light induced
iNOS expression in RPE cells. Bands were quantified based on pixel size/intensity/area
using Quantity One software (Bio-Rad). Graphs were plotted based on relative iNOS
expression using GraphPad Prism software.
3.4.3 Expression and localization of iNOS under oxidative stress
We tested our hypothesis whether oxidative stress controls iNOS expression in RPE cells
by using immunocytochemical analysis. Our fluorescent images show that iNOS
expression increased under oxidative stress (200 μM, t-BuOOH) compared to untreated
control as shown in figure 3.3A. A negative control without anti-iNOS primary antibody
confirmed that our immunocytochemical images are iNOS-specific (Figure 3.3B).
Nucleus staining with DAPI revealed cytoplasmic localization of iNOS.
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3.4.4 Oxidative stress induced protein nitration shown by 3-nitrotyrosine in the RPE
Formation of 3-nitrotyrosine is a post-translational modification caused by NO derived
peroxynitirite during pathophysiological conditions, which in turn alters protein structure
and function.

Our Western blotting analysis showed that relative protein nitration

increased in 30, 35, 37 kDa proteins and other proteins (55, 32, 20, 18, 10 kDa) under
oxidative stress (Figure 3.4 A). Reduction (3-nitro tyrosine to 3-amino tyrosine) with
disodium dithionite (Na2S2O4) confirmed the increased protein nitration in LPS, light and
oxidative stress treated samples (Figure 3.4 C).
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Figure 3.3A Increased expression of inducible nitric oxide synthase (iNOS) under
oxidative stress. ARPE-19 cells treated with tert-butyl hydroperoxide (200 μM for 36 or
48 hrs.) were analyzed by immunocytochemistry. Expression of iNOS is visualized by
the iNOS specific primary antibody, the Alexa Fluor 488-conjugated secondary antibody
(green, iNOS) and DAPI (blue, nucleus) staining. Expression of iNOS was observed
under oxidative stress condition in a time-dependent manner. Scale bars represent 20 μm.

56

Figure 3.3B Negative control of iNOS immunocytochemistry. iNOS expression in RPE
cells was confirmed by immunocytochemistry with Alexa-488 secondary antibody and
without anti-iNOS antibody as a negative control. Absence of green fluorescence
demonstrates that there are no non-specific binding proteins with Alexa-488 secondary
antibody. DAPI (blue) represents counter staining for the nucleus. Scale bars represent 20
μm.

Figure 3.4 A Increased protein nitration in RPE under oxidative stress. ARPE-19 cells
were treated with tert-butyl hydroperoxide (200 μM for 36 h). Cells were harvested, lysed
and proteins were separated by SDS-PAGE. A. Proteins with 3-nitrotyrosine were
visualized by Western blotting using anti-3-nitro tyrosine antibody (1:50 dilution).
Expression levels of nitrated proteins increased 2-3 folds under oxidative stress compared
to untreated control. Protein loading was controlled by probing with anti-β actin
antibody. B. Bands represent the expression of nitrated proteins quantified by pixel
intensity and area using Quantity One software (Bio-Rad). Quantitative analysis shows 23 fold increased expression of nitrated proteins under oxidative stress compared to the
untreated control. Graphs were plotted using GraphPad Prism software.
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Figure 3.4 C. Western blot analysis before and after reduction of nitrotyrosine to
aminotyrosine. Nitration reduction (NO2 to NH2) was performed to confirm protein
nitration, using disodium dithionite (Na2S2O4) to reduce 3-nitrotyrosine to 3aminotyrosine. Reduced tyrosine (3-aminotyrosine) showed no band on Western blotting
using3-nitrotyrosine antibody compared to control (3-nitrotyrosine). ARPE-19 cell lysate
from LPS, oxidative stress, and light treatment were separated by SDS-PAGE, and
proteins were visualized by Western blotting. PVDF membrane was chemically reduced
by 10 mM sodium dithionite (+ Na2S2O4 ) in 50 mM pyridine acetate buffer (pH 5.0) for
1 hr before probing by anti-nitrotyrosine antibody. Another PVDF membrane was
directly probed with anti-nitrotyrosine antibody without reduction (-Na2S2O4).
3.4.5 NO Induced Vimentin Dephosphorylation and PP2Ac Phosphorylation in the
RPE under Oxidative Stress
Oxidative stress disrupts RPE cell junction and barrier integrity which may cause the
pathogenesis of RPE related diseases through the degeneration of the blood-retinal barrier
(Bailey et al., 2004). Increased site-specific phosphorylation of vimentin induces
disassembly of vimentin intermediate filaments in vitro. Both cAMP dependent protein
kinase and protein kinase C dependent phosphorylation of Ser-38 residue, which is
located close to arginine substrate, were reported (Ando et al., 1989). To determine NOdependent cytoskeletal change that is regulated by PP2A phosphorylation signaling, we
examined the interconnection of NO-vimentin-PP2A signaling (Figure 3.5). Cells were
treated with or without oxidative stress, L-arginine, and a NOS antagonist (N'1-nitro-Larginine methyl ester, L-NAME). Cells treated with oxidative stress showed downregulation of the anti-apoptotic protein p-PP2Ac relative to the control group. Bcl-xL is
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also an anti-apoptotic protein and is down-regulated in all samples that are exposed to
oxidative stress. Bcl-xL expression increased in cells treated with L-arginine (2 mM)
under oxidative stress. However, cells treated with oxidative stress, arginine, and LNAME together at the same time had lowest expression of Bcl-xL. Our data implies that
increased levels of NO by L-arginine may have a protective role towards RPE cells under
oxidative stress by inducing anti-apoptotic molecules, including Bcl-xL. Vimentin
phosphorylation is up-regulated in cells under stress. Cells treated with L-arginine (2
mM) down-regulated vimentin phosphorylation whereas L-NAME along with L-arginine
up-regulated vimentin phosphorylation under oxidative stress. This is likely a result of
increased cytoskeletal restructuring due to changes of intermediate filaments. We then
asked whether NO can induce PP2Ac catalytic subunit phosphorylation in the RPE under
oxidative stress.

Figure 3.5A. NO dependent concentration changes of p-Vimentin (Ser38), p-PP2Ac
(Tyr307) and Bcl-xL under oxidative stress. ARPE-19 cells were incubated with tertButyl hydroperoxide (200 μM) or L-Arginine (2 mM) or L-NAME (2 mM) for 24 hrs in
serum free media. Cells were harvested, lysed in RIPA lysis to extract proteins. Proteins
were separated by SDS-PAGE and probed with anti- p-vimentin (Ser38), anti- p-PP2Ac
(Tyr307) and anti- Bcl-xL antibodies to visualize the expression by Western blotting.
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Figure 3.5B Quantitative analysis of Figure 3.5A. Y axis represents relative
phosphorylations in arbitrary unit (a.u.). X axis represents lanes. Lane 1. Control cells
without treatments; Lane 2. Cells treated with 200 μM tert-butyl hydroperoxide only
(oxidative stress); Lane 3. Cells treated with 200 μM tert-butyl hydroperoxide and 2 mM
L-Arginine; Lane 4. Cells treated with 200 μM tert-butyl hydroperoxide and 2 mM LNAME; Lane 5. Cells treated with 200 μM tert-butyl hydroperoxide, 2 mM L-Arginine
and 2 mM L- NAME.
Stimulation of endothelial cells with LPS and IFNγ increases NO-derived peroxynitrite.
Up-regulation of peroxynitrite induces PP2Ac tyrosine nitration and nitrated PP2Ac
inhibits PP2Ac phosphorylation. Activation of PP2A by nitration in turn causes
endothelial barrier dysfunction (Bailey et al., 2004). We tested whether phosphorylation
of PP2Ac is down-regulated under oxidative stress in RPE cells. Arginine treatment
under oxidative stress shows up-regulated PP2Ac phosphorylation compared to oxidative
stress only condition. Arginine treatment with or without L-NAME under oxidative stress
clearly demonstrated that PP2Ac phosphorylation is down-regulated compared to nonstress control.
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3.4.6 NO Induced anti-Apoptotic Signaling in the RPE under Oxidative Stress.
Anti-apoptotic protein Bcl-xL plays a significant role in RPE cell survival under normal
and oxidative stress conditions. Reduced Bcl-xL expression levels confer apoptotic cell
death in the RPE (Bailey et al., 2004). Inhibition of Bcl-xL expression alters RPE
morphology and diminishes cell survival (Bailey et al., 2004) . We examined whether NO
regulates anti-apoptotic signaling via Bcl-xL. While arginine addition increased Bcl-xL,
NO reduction by L-NAME down-regulates Bcl-xL compared to oxidative stress only.
This result suggests that vimentin phosphorylation may regulate apoptotic cell death
signaling in RPE cells. Moreover, increased NO may play a protective role by enhancing
anti-apoptotic signaling in the RPE under oxidative stress. Our data shows that Bcl-xL
expression levels decreased in the RPE under oxidative stress. RPE cells treated with
arginine shows increased expression of Bcl-xL under oxidative stress.
3.4.7 Light induced vimentin filament disorganization in the RPE
Interactions between microfilaments, intermediate filaments, and microtubules, stabilize
structural, cytoskeletal organization of RPE cells. Vimentin is a major intermediate
filament, which is responsible for cell adhesion, migration and signaling (Owaribe et al.,
1986). To investigate whether light stress may induce morphological changes through
vimentin, we performed immunostaining with fluorescently labeled antibodies as shown
in figure 3.6. Control cells in the dark show that vimentin filaments are extended
throughout cytoplasm. Nuclear morphology appears as oval shaped and is intact. Intense
light induced dramatic morphological changes as rounded vimentin filaments rather than
extended form. Nuclear size decreased; major radius reduced to 60-50% and minor radius
diminished 80-70% in length under intense light at 20 hrs compared to control. A patchy
green color around the nucleus represents vimentin filament disorganization.
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Figure 3.6 Vimentin filament changes in the RPE under light induced stress. ARPE-19
cells were exposed to bright intense light (7000 Lux) for different time points (16 hrs and
20 hrs). Cells were fixed in methanol at -20 ℃. Vimentin was probed by anti-vimentin
and anti-goat Alexa 488 secondary antibody (green, vimentin filaments) and DAPI
counterstaining (blue, nucleus). Scale bars represent 20 μm.
3.4.8 Apoptosis Mediated Morphological Changes of RPE under Oxidative Stress
Morphological changes of the RPE are associated with various pathological conditions
involved in many posterial ocular diseases. Our scanning electron microscopy analysis of
RPE cells under oxidative stress demonstrates that the lateral, basal and apical cell
surfaces of RPE are changed during apoptosis. RPE cells were treated with 100 μM of
H2O2 for 2 hrs. RPE cells under stress show that apoptotic cell surface changes by
forming protrusion (Figure 3.7B), developing bubble-like blebs on their surface (Figure
3.7C), phagocytic alteration like membrane disruption (Figure 3.7D) apical, basal and
lateral surface changes, including dense projection of microvilli (Figure 7EF), broken
into small, membrane-wrapped fragments (Figure 3.7GH). These results demonstrate that
morphological changes of RPE cells under oxidative stress may lead to cell lysis,
cytoskeleton collapse, and ultimately cell death.
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Figure 3.7 Cytoskeletal changes of RPE cells under oxidative stress were identified using
scanning electron microscope (SEM). ARPE-19 cells were treated with H2O2 (100 μM
for 2 hrs). After fixation with 3% paraformaldehyde and 0.1% glutaraldehyde in
phosphate buffer, morphological changes of ARPE-19 cells were observed using JEOL
JSM-6400 SEM at 4000 X magnification. A. Control, B-H. Sequential morphological
changes of ARPE-19 cells under oxidative stress. Scale bar represent 8 µm.
3.5 Discussion
Oxidative stress-induced apoptosis is the final cell death pathway in many irreversible
ocular diseases (Chang et al., 1993; Porteracailliau et al., 1994). While the end point of
apoptosis is well established, the knowledge of early biochemical reactions and
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molecules has been elusive. We have examined early biosignatures and mechanisms of
retinal and RPE cell death under oxidative stress (Arnouk et al., 2011b; Chung et al.,
2009b; Lee et al., 2010c; Lee et al., 2011; Sripathi et al., 2011c; Zhang et al., 2010b). Our
previous studies demonstrated that not only intense light but also constant moderate light
and mild oxidative stress may trigger induction of anti-apoptotic Bcl-xL and
erythropoietin as well as pro-apoptotic caspases. NO is generated from the oxidation of
the guanido nitrogen of its substrate L-arginine with the stoichiometric formation of Lcitrulline by nitric oxide synthase in the presence of oxygen and NADPH. Enzymatic NO
formation is involved in physiological processes, including the control of vascular tone,
inhibition of platelet aggregation, smooth muscle cell replication, immune response, and
wound healing processes (Mann and Motterlini, 2007). NO has been recognized for its
paradoxical role as a promoter of cell growth (vascular neogenesis) and cell death
apoptosis (Mocellin et al., 2007; Rose and Mascharak, 2008). Exposure to intense light
may induce protein nitration via iNOS activation in the retina, which in turn mediates
photoreceptor cell death (Palamalai et al., 2006). Elevated tyrosine nitration was observed
in the inner segments of photoreceptors and RPE upon intense light exposure due to
increase NO production (Miyagi et al., 2002). Inflammatory response and high oxygen
demand in the retina are expected to increase NO generation and oxidative damage to
Bruch’s membrane and could lead to pathophysiological protein nitration (Miyagi et al.,
2002). NOS is categorized into three isoforms such as calcium-dependent neuronal
(nNOS), endothelial (eNOS) isoforms, and the inducible, calcium independent isoform
(iNOS), which are related to neuronal communication, vasolidation and inflammation
signaling, respectively (Knowles and Moncada, 1994; Marletta, 1993). Optimum
expression levels of NOS isoforms are tightly regulated for normal retinal cell
homeostasis and RPE phagocytosis. A high concentration of NO could lead to the
accumulation of protein aggregates between photoreceptors and RPE cells, which results
in photoreceptor degeneration (Knowles and Moncada, 1994). Light-induced oxygen
radicals are mediators of retinal photic injury, based on the observation of the protective
effect of free radical scavengers in the light damaged model (Knowles and Moncada,
1994). However, decreased expression of eNOS and nNOS were also observed in
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neuronal and vasoconstrictive changes in AMD choroid. Changes of NOS in AMD
suggest that retinal degeneration is directly or indirectly related to local NO concentration
in the RPE. NO reacts with superoxide anion (O2.-) to produce peroxynitrite (ONOO-), a
potential cytotoxic and tyrosine nitrating molecule under oxidative stress (Knowles and
Moncada, 1994). Peroxynitrite modulates tyrosin phosphorylation and dephosphorylation
during postsynaptic compartments during cell regulation (Di Stasi et al., 1999).
Exogenous NO exposure also resulted in cytoskeletal reorganization through
phosphorylation of VASP (vasodilator-stimulated phosphoprotein) in diabetes model
(Calzi et al., 2008). The current study suggests that NO may regulate phosphorylation of
PP2Ac and vimentin as a physiological regulator of cell respiration to become an agent of
cell pathology. In addition, the excessive level of NO or the deficiency of NO may
control endothelial dysfunction under oxidative stress. Our results demonstrate that
oxidative stress induced disassembly of vimentin intermediate filaments may cause
vimentin phosphorylation in the RPE. L-Arginine uptake by RPE cells significantly
increases the NO levels in diabetic rat RPE (Calzi et al., 2008). The current study implies
dual roles of NO with 1-10 nmole of NO may protect RPE cell by PP2A and vimentin
phosphorylation, whereas higher NO (>100 nmole) generation under oxidative stress may
induce apoptosis. Our results show that arginine treatment under oxidative stress
significantly decreases vimentin phosphorylation compared to no arginine treatment
under oxidative stress. Treatment of NOS antagonist, N'1-nitro-L-arginine methyl ester
(L-NAME) along with arginine under oxidative stress, shows that vimentin
phosphorylation increased compared to arginine only. Addition of both arginine and LNAME under oxidative stress reveals that vimentin phosphorylation has positive and
negative correlations with NO under oxidative stress.
Based on our observations in the current study, we postulate that light may induce posttranslational modifications of target proteins, including vimentin and PP2Ac. We
speculate that PP2Ac phosphorylation may control its subunit binding that determines its
phosphatase activity and substrate specificity under stress conditions. A stabilized
vimentin may act as an anti-apoptotic agent when cells are under stress. Our previous
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results demonstrated that PP2A and vimentin are modulated by constant light, and are
key elements involved in cytoskeletal signaling in rd1 mutation model (Zhang et al.,
2010b). A positive correlation between the levels of PP2A and vimentin under lightinduced stress suggests that cytoskeletal dynamics are regulated by phosphorylation of
vimentin.
PP2A is a heterotrimeric serine/threonine phosphatase, which ubiquitously performs
dephosphorylation reactions in cell signaling cascades, including Raf, MEK, and AKT.
The regulatory subunit PP2Ab enhances the formation of stable complexes between
PP2Aa-c. PP2A positively regulates apoptosis by controlling pro-apoptotic (Bad, Bak,
Bax) and anti-apoptotic (Bcl-xL) Bcl-2 family members (Medearis et al., 2011). PP2A
dephosphorylates phosducin, a phosphoprotein which modulates the light activated
phototransduction cascade in vertebrate retina (Wu and Wilson, 2009). Suppression of
endogenous PP2Aa by 50% leads to cell transformation; further suppression results in
cell cycle arrest and apoptosis. This suggests that the suppression of PP2A a or c levels
induce apoptosis and that a minimal level of PP2A a or c is required for cell survival
(Chen et al., 2005). Under light condition, efficient dephosphorylation of phosducin by
PP2A is required to quench high sensitivity so that more intense light can be sensed.
PP2Ac tyrosine residue undergoes nitration by peroxynitrite that correlates with
decreased tyrosine phosphorylation and increased dephosphorylation activity (Monteiro
et al., 2008). Although the potential importance of protein dephosphorylation as a
therapeutic target has been appreciated, no detailed approach to date has been made that
targets PP2A, especially on retinal degeneration (Kalev and Sablina, 2011; Tanimukai et
al., 2009). Abnormalities in PP2A activity and concentration have been linked to
neurodegenerative diseases, including Alzheimer’s and Parkinson’s. However, the
mechanism by which PP2A activity is regulated under oxidative stress remains largely
elusive. Recent advances in the structural investigation and the light-driven switch
mechanism have elucidated PP2A-induced dephosphorylation signaling in the retina
(Brown et al., 2002; Cho and Xu, 2007; Xu et al., 2006). Modulating light-induced posttranslational modifications of PP2A and vimentin through NO signaling may assist in
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maintaining the proper filament network in Müller cells, which subsequently supports
cell survival and architecture in the retina and RPE.
Our results demonstrate that NO concentration and duration may influence cytoskeletal
dynamics and apoptotic pathway via phosphorylation signaling under stress conditions.
As progressive loss of neuronal structure precedes cell death, our data elucidates the
regulatory mechanism of cytoskeletal organization governed by NO and PP2A/vimentin
phosphorylation. These outcomes are expected to have an important positive impact,
because modulation of NO might be assigned as a therapeutic intervention to serve as the
pathological target for the balanced phosphorylated cytoskeleton (Thomas et al., 2004;
Thomas et al., 2008).
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4.1. Abstract
Oxidative stress contributes towards the disruption of mitochondrial structural integrity,
cytoskeletal reorganization and differential expression of pro or anti apoptotic proteins
and further leads to progressive cell death of retina and RPE. Our previous study
demonstrates that prohibitin levels are upregulated in the retina but downregulated in the
RPE of aging and diabetic model.

Differential expression of prohibitin and the

identification of interacting proteins in the retina and retinal pigment epithelium (RPE)
may provide insights into apoptotic signaling mechanism during the progression of
retinal degenerative diseases such as age-related macular degeneration (AMD) and
diabetic retinopathy (DR). In this study differential expression of prohibitin and its
regulation

is

studied

immunoprecipitation,

using

proteomic

two-dimensional

strategies

including

electrophoresis

and

western

blotting,

MALDI-TOF

mass

spectrometry. Our western blotting analysis reveals that prohibitin levels are decreased in
the retinas of diabetic retinopathy but the levels are significantly elevated in the aged
retinas from mouse, rat models and human donor eyes. Prohibitin levels in the central and
peripheral retina are increased but the levels are decreased in the central and peripheral
RPE of human AMD eyes. Our mass spectrometry analysis reveals that prohibitin might
interact with phospholipid binding receptors, mitochondrial structure determinant
proteins and anti-apoptotic regulatory proteins. In the present study we propose that
prohibitin levels in the retina and RPE determines the mitochondrial stability, function
and apoptotic signaling during the progression of age-related macular degeneration
(AMD) and diabetic retinopathy (DR).
4.2 INTRODUCTION
Mitochondrial dysfunction that includes oxidative damage and altered energy levels leads
to accelerated aging and age-related diseases. Age-related macular degeneration (AMD)
involves progressive cell death of post-mitotic retinal pigment epithelial (RPE) cells,
which then adversely affects rod and cone survival. AMD is characterized in its early
stages by the presence of extracellular deposits, known as drusen, that accumulates
between the basal surface of the RPE and Bruch’s membrane. Oxidative stress and
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uncontrolled activation of the alternative complement pathways, especially at the
membrane surface of RPE cells, are thought to be independently associated with AMD.
Emerging evidence suggests that development and progression of AMD involves
significant alteration in cell signaling proteins especially apoptosis and immune
signaling. However, the identity of the molecules responsible for triggering activation of
RPE apoptosis, as well as the downstream molecular interactions that promote AMD
pathology, remain elusive. We have been actively seeking early molecular signaling
events under oxidative stress in the retina and RPE using a proteomics and metabolomics
approach to identify new biomarkers of retinal degeneration (Arnouk et al., 2011b;
Chung et al., 2009a; Jahng, 2012; Lee et al., 2010a; Lee et al., 2010b; Lee et al., 2011;
Sripathi et al., 2012; Sripathi et al., 2011c; Zhang et al., 2010b). This approach
demonstrated that prohibitin is involved in oxidative stress signaling in vitro and in vivo.
Prohibitin was originally identified as an anti-proliferative protein (McClung et al.,
1995a) that is highly conserved from bacteria to human suggesting essential cellular
survival function (Nuell et al., 1991). However, the molecular mechanism of prohibitin
on aging and lipid metabolism is not clearly understood. For the last twenty years,
prohibitin has been proposed to have a role as a cell cycle inhibitor (Mcclung et al.,
1995b), a transcriptional regulator (Fusaro et al., 2003b; Wang et al., 2002a), an
inflammatory modulator (Sharma and Qadri, 2004b; Theiss et al., 2007a), a plasma
membrane receptor (Kolonin et al., 2004b), a mitochondrial chaperone (Nijtmans et al.,
2000b; Sanz et al., 2004) and a lipid binding shuttle (Sripathi et al., 2011b). Prohibitin is
involved in apoptosis and aging by stabilizing newly synthesized respiratory enzymes,
however, its presence and function in the eye has been elusive. Localization of prohibitin
has been controversial, being mitochondrial, nuclear, or cell surface, possibly due to
different cell type and lipid membrane environment. Our previous biochemical
experiments demonstrated that prohibitin is a lipid binding shuttle primarily expressed in
mitochondria, however, it translocalizes to the nucleus under stress condition. The extent
of prohibitin localization in mitochondria inversely correlates with levels of oxidative
stress. Knockdown approach using siRNA suggests that prohibitin may have the antiapoptotic function through Bcl-2 and mitochondrial DNA binding mechanisms. Our data
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further suggests that specific lipid-binding mechanisms involving altered cardiolipin
interactions might be the key element to determine prohibitin shuttling between
mitochondria and the nucleus. Mitochondrial dysfunction is associated with AMD and
our studies also suggest specific patho-physiological mechanisms involving altered
mitochondrial disruption. The current in vivo models and molecular interaction studies,
inlcuding lipid, nucleotide and protein with prohibitin, may provide a new insight into the
underlying mechanisms involved in the development and progression of AMD and
further suggest the relationship between various risk facotors, such as oxidative stress and
aging. Such information are critical for the development of more effective therapeutic
strategies for the treatment of AMD.
4.3 MATERIALS AND METHODS
4.3.1 ARPE-19 and HRP Cell Culture
Human retinal progenitor (HRP) cells and human retinal pigment epithelial (ARPE-19)
cells were obtained from University of North Texas Health Science Center and ATCC
(Manassas, VA) respectively. Cells were cultured in 56.7 cm2 dishes (Nunc, Naperville,
IL) containing Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) and 1% penicillin/ streptomycin and the flasks placed in a 5%
CO2 incubator at 37 °C. Confluent cells were retrypsinized with a 0.1%trypsin-EDTA
(Sigma, St. Louis, MO) for 5-7 min at 37 °C. After centrifugation (125g for 7 min), cells
were plated in fresh culture dishes and allowed to grow to confluence for 2−4 days.
Eight- to nine -passage cells were used for oxidative stress treatment.
4.3.2 Oxidative Stress Treatment
To induce oxidative stress in vitro confluent HRP and ARPE-19 cells were incubated
with 200 μM of tert-butyl hydroperoxide (Sigma, St. Louis, MO) in serum free medium
for 1 hr and 2 hrs respectively. Cells were washed twice with PBS before being
harvested. Cells were lysed using mild detergent based lysis buffer to perform coimmunoprecipitation with prohibitin antibody.
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4.3.3 Treatment of Animals
Adult male Sprague-Dawley (SD) rats (250-300g) and mice (C57 black) obtained from
Charles River Laboratories (Wilmington, MA) were made diabetic by intravenous
injection with streptozotocin (STZ) (Sigma, St. Louis, MO) (65mg/kg dissolved in 0.1M
sodium citrate [pH 4.5]. Control rats and mice were delivered injections of vehicle
alone.

Rats and mice were considered to be diabetic at blood levels >350

mg/dL. Animals were sacrificed 2 and 4 weeks following onset of diabetes by an
overdose of anesthesia. Comparative analysis was conducted with an identical animals
strain (SD). Control SD rats and mice were sacrificed at 12 weeks of age and aged SD
rats and mice were sacrificed at 52 and 54 weeks of age. Retinas of SD rats and mice
were removed and snap frozen in liquid nitrogen. Retinas from different subgroups were
collected and were prepared for biochemical analysis.
4.3.4 Donor Eye Tissues
Human diabetic retinopathy (DR), aged and control retinal tissue was obtained from
Georgia eye bank.

Human age-related macular degeneration (AMD) retinal (8mm

macular and peripheral) and RPE (8mm macular and peripheral) and age matched control
eye tissue was provided by the Lions eye bank at University of Utah, UT.
4.3.5 Co-Immunoprecipitation
HRP and ARPE-19 cells were washed once with 1X Modified Dulbecco’s PBS and lyse
the cells by adding ice cold IP lysis buffer [25 mM Tris, 150 mM NaCl, 1mM EDTA, 1%
NP-40, 5% glycerol; pH 7.4 and protease inhibitor cocktail] by incubating on ice for 5
min and periodic sonication (3 × 5 min) followed by centrifugation at 13,000 × g for 10
minutes to pellet the cell debris. Proteins in the supernatant were pre cleared using
control agarose resin, cross-linked by 4% bead agarose, to avoid the nonspecific binding.
The anti-prohibitin antibody immobilization is performed using amino-linked protein- A
beads by coupling buffer [1 mM sodium phosphate, 150 mM NaCl (pH 7.2)] followed by
incubation with 3 μL of 5 M sodium cyanoborohydride solution on rocker at RT for 2 hrs
to make the slurry suspended. Columns were briefly washed with a wash solution [1M
NaCl] and protein lysate was incubated in the protein A-antibody column with gentle
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rocking for overnight at 4 °C. Spun down the unbounded proteins as flow through and the
columns were washed thrice with wash buffer to remove nonspecific binding proteins.
Elute the interacting proteins by incubating with elution buffer for 5 min at RT. Finally
the eluted proteins were equilibrated with 5X Laemmli sample buffer with the final
concentration of 10% β- mercaptoethanol. Eluted proteins were resolved on SDS−PAGE
and interacting protein bands were visualized by either coomassie (Pierce, IL) or silver
staining (Bio-Rad, Hercules, CA).
4.3.6 In-Gel Digestion and MALDI TOF Mass Spectrometry
Selected protein bands from gels were excised into cubes (ca. 1×1 mm). The coomassie
stained gel pieces were destained twice with 200 μL of 50% acetonitrile (MeCN)/25 mM
NH4HCO3 buffer (pH 8.0) at room temperature for 20 min, whereas the silver stained gels
pieces were destained by soaking in 1:1 mixture of 30 mM potassium ferricyanide and
100 mM sodium thiosulfate for 5 min until the silver stain disappears and washed the gel
pieces thrice with water. Incubate the gel pieces once with 200 μL of 100% MeCN until
they become white and shrink, and vacuum-dried with a Speed Vac concentrator (Savant,
Holbrook, NY). Reduce the proteins with 10 mM DTT in 100 mM NH4HCO3 for 30 min
at 56 ºC in an air thermostat and alkylate with 55 mM iodoacetamide in 100 mM
NH4HCO3 for 20 min at RT in dark. The gel pieces were saturated with 13 ng/μL
sequencing grade modified trypsin (Promega, Madison, WI) in 10 mM NH4HCO3
containing 10 % (vol/vol) MeCN and incubated the samples in air circulation thermostat
at 37 °C for overnight. Subsequently, the peptides were enriched twice with 50 μL of a
50% MeCN/5% formic acid mixture for 20 min at 37 °C in a shaker. The solution
containing peptide mixture is completely vacuum dried. The dried peptide is dissolved in
5-10 μL of 75% MeCN/1% TFA solution. The matrix α-cyano-4-hydroxycinnamic acid
(5 mg/mL CHCA, MW 189.04 Da) (Sigma, St. Louis, MO) is freshly dissolved in 50 %
acetonitrile/1% triflouroacetic acid (TFA) and centrifuged at 13,000 g for 5min. The clear
matrix solution is mixed with the tryptic digested peptide and spotted the 0.5 μL of the
matrix/peptide mixture on to the MALDI target (Ground steel, Bruker Daltonics,
Germany) and allowed to form dried droplet of the sample. Commercially available
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target with pre-spotted known peptide samples were used to calibrate the accuracy of
instrument. The mass spectra range of 800-3000 Da with the laser intensity of 70-75%
and 100-300 shot numbers, was measured using Flex control MALDI-TOF mass
spectrometry (Bruker Daltonics, Germany). Internal calibration for all the mass spectra
were performed based on the autolysed trypsin (Promege) products (m/z 842.509 and
2211.105). Data analysis was performed using Flex analysis software (Bruker). Protein
database is performed using Mascot search engine software (Matrix Science) along with
the NCBI/SwissProt database(s) and followed the different parameters such as Taxonomy
- Homo sapiens; allowed zero mismatch cleavage with fixed carbamidomethyl (C)
modification of cysteine and variable modification of methionine oxidation. 100-300 ppm
was considered as peptide mass tolerance. Peptide identification is considered based on
the MASCOT Mowse scores, number of matched peptides and protein sequence
coverage.
4.3.7 Immunocytochemistry
ARPE-19 cells were cultured on sterile glass cover slips with DMEM/F12 medium
supplemented with 10% FBS and 1% penicillin–streptomycin (Hyclone) in 5% CO2
incubator at 37 °C. Cells were treated with 200 μM of hydrogen peroxide for 2 hrs to
induce oxidative stress. Cells were briefly washed with PBS and incubated with the final
concentration 100 nM MitoTracker Orange CMTMRos (Molecular Probes, Carlsbad,
CA) in serum free culture medium for 30 min at 37 °C. Cells were washed with PBS and
fixed with 10% formaldehyde for 30 min at RT. After fixation, cells were treated in
0.2% Triton X-100 (Sigma) in PBS for 30 min to permeabilize the cell membrane and
the cells were blocked with complete medium containing 10% FBS and 0.05% Tween-20
(Sigma) for 1 hr. Cells were probed with anti-prohibitin antibody (1:1000; Genemed
Synthesis Inc, San Antonio, TX) for overnight at 4 °C. Cells were washed with PBS and
incubated with Alexa Fluor 488-conjugated anti-rabbit IgG secondary antibody (1:700;
Molecular Probes) for 1 h at RT. To counter stain the nucleus, cells were mounted with
VECTASHIELD mounting medium containing DAPI (4,6-diamidino-2-phenylindole).
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Images were acquired on fluorescent microscope (Zeiss AxioVert 200 M Apo Tome)
with 63× magnification. Images were analyzed and merged using ImageJ software (NIH).
4.3.8 SDS−PAGE and Western Blot Analysis
Protein quantification was performed using BCA protein assay kit (Pierce) by plotting
BSA standard curve graph. Protein samples were dissolved in 5X Laemmli sample buffer
(240 mM Tris pH 6.8, 8% SDS, 40% glycerol, 0.4% bromophenol blue, 10% βmercaptoethanol) followed by denaturation at 90°C for 10 min. Proteins were resolved
using 8-16% gradient polyacrylamide precast gels (Bio-Rad), followed by electrotransfer
on to the methanol activated PVDF membrane (Bio-Rad) using semidry transfer by
applying 15V for 30 min. Non-specific proteins were blocked with 5% nonfat dry milk
(Bio-Rad) prepared in TBS with 0.1 % (v/v) Tween-20 for 2 hr at 4°C. Membranes were
probed with primary antibody prohibitin (Rabbit polyclonal, 1:1000; Genemed Synthesis
Inc. TX) at 4 °C for overnight on a shaker. Subsequently, the membrane is incubated with
anti-rabbit HRP conjugated secondary antibody (1:10000; Agrisera, Vännäs, Sweden) for
2 h at room temperature on shaker. Antibody probed membranes were developed with
West Pico Chemiluminescent Substrate (Pierce) for 1-2 min. The immunoreactive protein
bands (signal) were visualized by LAS 4000 mini luminescent image analyzer (GE,
Piscataway, NJ).

Membranes were reprobed with the β-actin (mouse monoclonal,

1:5000; Sigma, St. Louis, MO) followed by the incubation with anti-mouse HRP
conjugated secondary antibody (1:7,000; Santa Cruz Biotechnology Inc, CA) for loading
control. All the immunoblots were performed in triplicate. Bands were quantified based
on pixel size/intensity/area using Quantity One software (Bio-Rad) and graphs were
plotted based on relative intensity of bands using GraphPad Prism software.
4.4 RESULTS
4.4.1 Prohibitin Expression Downregulated in the Retina of the Diabetic Model
Prohibitin regulates lipid metabolism by binding specific phospholipids, including
cardiolipin and PIP3 (Sripathi et al., 2011c). Increased prohibitin levels negatively affect
insulin signaling through tyrosine phosphorylation as phosphatidylinositol-3 kinase
(PI3K) downstream (Ande and Mishra, 2009). We tested our hypothesis that prohibitin
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signaling could be altered in diabetic pathway or aging model. We examined whether
mitochondrial prohibitin was altered during hyperglycemic condition using streptozotocin
(STZ)-treated murine or diabetic human model. Our Western blotting analysis showed
that the prohibitin levels decreased significantly in the diabetic retina from the STZinduced mouse and rat (Figure 4.1-3). Next, considering reactive oxygen species (ROS)
accumulation leads to the disruption of mitochondrial network during aging, we tested
our hypothesis that prohibitin expression could be changed in aged retinas from mouse,
rat (12 months), and human (71 years) compared to controls. In contrast to diabetic
condition, we observed that the level of prohibitin is significantly increased in rats and
humans, whereas minimum changes in elevated expression in the mouse retina (Figure
4.1-3).

Figure 4.1 Expression difference of mouse retinal prohibitin (PHB) in control, diabetic
retinopathy (DR) and aged retina was analyzed by western blotting. Retinal tissue from
was homogenized in RIPA buffer followed by sonication. Proteins were separated by
SDS-PAGE and PHB expression was visualized by western blotting. β-actin blot was
used as a loading control. Bands were quantified based on pixel size/intensity/area using
Quantity One software (Bio-Rad). Graphs were plotted based on relative prohibitin
expression using GraphPad Prism software.
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Figure 4.2 Expression difference of rat retinal prohibitin (PHB) in control, diabetic
retinopathy (DR) and aged retina was analyzed by western blotting.

Figure 4.3 Expression difference of human retinal prohibitin (PHB) in control, diabetic
retinopathy (DR) and aged was analyzed by western blotting.
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4.4.2 Prohibitin Expression Increased in the Retina but Decreased in the RPE of
AMD
The increased levels of reactive oxygen species under oxidative environment may initiate
various pathophysiological events in the retina and RPE. Differences in region-specific
protein content were reported in central and peripheral retina in the progression of AMD
(Lee et al., 2010c). Since the susceptibility towards oxidative stress significantly varies
from the retina and RPE cells, we aimed to analyze prohibitin expression in the macular
and peripheral retinal and RPE region. Our Western blot analysis demonstrates that the
prohibitin levels increased significantly in both macular (8 mm) and peripheral retinal
region from the postmortem donor eyes of AMD (Figure 4.4). However, prohibitin levels
decreased dramatically in both macular RPE region and peripheral RPE in AMD eyes
compared to age matching controls, suggesting mitochondrial dysfunction and RPE cell
death in AMD (Figure 4.5). β-tubulin expression was used as a loading control.

Figure 4.4 Expression difference of prohibitin (PHB) in human Age-related Macular
Degeneration (AMD) retina (8mm macular, peripheral retina) was analyzed by western
blotting. Retinal tissue and RPE cells were homogenized in RIPA buffer followed by
sonication. Proteins were separated by SDS-PAGE and PHB expression was visualized
by western blotting. β-tubulin blot was used as a loading control. Bands were quantified
based on pixel size/intensity/area using Quantity One software (Bio-Rad). Graphs were
plotted based on relative prohibitin expression using GraphPad Prism software.
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Figure 4.5 Expression difference of prohibitin (PHB) in human Age-related Macular
Degeneration (AMD) retinas (8mm macular, peripheral retina) were analyzed by western
blotting. RPE cells were homogenized in RIPA buffer followed by sonication. Proteins
were separated by SDS-PAGE and PHB expression was visualized by western blotting.
β-tubulin blot was used as a loading control. Bands were quantified based on pixel
size/intensity/area using Quantity One software (Bio-Rad). Graphs were plotted based on
relative prohibitin expression using GraphPad Prism software.
4.4.3 Prohibitin Depletion in the RPE
To examine prohibitin depletion phenotype as shown in the RPE of AMD eyes, we
determined a loss of function study using prohibitin-targeting small interfering RNA
(siRNA). Prohibitin knockdown experiment demonstrates that a decreased level of
prohibitin disrupts the regular lamellar cristae whereas random sequence control and t=0
control does not affect the structure of mitochondria. The mitochondrial morphology,
visualized by MitoTracker, showed that prohibitin silencing led to mitochondrial
fragmentation instead of the tubular shape as shown in control cells (Figure 4.7). Then we
examined prohibitin expression and mitochondrial morphological differences in RPE
under oxidative stress. Our immunocytochemical analysis of retinal pigment epithelial
cells (ARPE-19) shows that the disrupted mitochondrial morphology under oxidative
stress (200 µm H2O2) compared to the untreated control (Figure 4.7). However, we found
no difference in the nuclear DNA morphological aberration between oxidative stress and
control. MitoTracker Orange (mitochondria, red, 578 and 599 mm for absorption and
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emission), DAPI (nuclear DNA, blue, 369 nm absorption and 460 nm emission) and
Alexa Fluor 488 (prohibitin, green, 495 nm absorption and 519 nm emission) were used
to label subcellular organelles and prohibitin, respectively.

Figure 4.6 Depleted levels of prohibitin are shown by siRNA knockdown analysis.
ARPE-19 cells were transfected by prohibitin specific siRNA in serum free medium by
time dependant manner (36 to 72 h). Prohibitin expression and depleted levels were
analyzed by Western blotting analysis form cell extracts. Prohibitin levels were
diminished during siRNA knockdown analysis. β-actin expression levels were considered
as a loading control.

Figure 4.7 Mitochondrial morphological changes during prohibitin siRNA knockdown
analysis. ARPE 19 cells were treated with prohibitin specific siRNA (175 ng for 48 h)
and random sequence control were analyzed by immunocytochemical analysis.
Subcellular organelles and prohibitin levels were visualized by DAPI (blue, nucleus),
MitoTracker Orange (red, mitochondria) and the prohibitin-specific primary antibody, the
Alexa Fluor 488-conjugated secondary antibody (green, prohibitin).Disrupted
mitochondrial morphological changes were observed under prohibitin depleted levels.
The scale bar is 5 μm.
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4.4.4 Prohibitin-Lipid Interaction
We next asked whether prohibitin in various organelles or cells may have different
cardiolipin affinity to test subcellular organelle-specific prohibitin-lipid interactions.
Previously, the prohibitin-lipid binding assay demonstrated that prohibitin binds with
cardiolipin, a major mitochondrial phospholipid, under oxidative stress (Sripathi et al.,
2011a). The lipid interaction assay demonstrates that microsomal and cytosolic prohibitin
showed stronger interaction compared to mitochondrial and nuclear prohibitin (Figure
4.8). In addition, prohibitin from bovine RPE or ARPE19 cells did not show any
interaction with cardiolipin, however, prohibitin from the bovine retina showed
cardiolipin binding. Microsomal prohibitin showed strong interaction with cholesterol
and weaker interaction with phosphatidylserine. To determine cardiolipin and cholesterol
changes under oxidative stress, relative lipid concentrations were analyzed by mass
spectrometry. Cardiolipin decreased 20% under 200 µM H2O2 in a time and dose
dependent manner (Figure 4.8) and cholesterol/cholesterol ester increased roughly 2.5
fold (data not shown). Addition of cholesterol (125-250 µM) to APRE19 cells during cell
culture down-regulated prohibitin and prohibitin2 expression (Figure 4.9). Addition of
beta-cyclodextrin increased prohibitin expression (data not shown). Our data suggests
that prohibitin from a different subcellular organelle or different cells may have a
different affinity to cardiolipin. Further, our data may suggest that prohibitin expression
has inverse correlation with cholesterol concentration.
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Figure 4.8 Subcellular prohibitin-lipid binding analysis. Blotting hybridization with
PHB-antibody shows that subcellular PHBs have different binding affinity with
cardiolipin, cholesterol and phosphatidylserine. Retina PHB and cardiolipin have strong
binding affinity, while bovine RPE and human RPE (ARPE-19) PHB have weak binding
affinity. Retinal microsomal PHB binds have high binding affinity with cardiolipin,
cholesterol, and phosphotidylserine. Microsomal fraction applied onto PVDF membrane
is considered as a negative control.

Figure 4.9 Quantitative analysis of Subcellular prohibitin-lipid binding: Spots were
quantified based on pixel size/intensity/area using Quantity One software (Bio-Rad).
Graphs were plotted based on relative prohibitin expression using GraphPad Prism
software.
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4.4.5 Prohibitin-Nucleotide Interaction
To understand the origin of mitochondrial dysfunction by prohibitin depletion, we next
asked the question of prohibitin-nucleotide interaction. Under oxidative stress,
mitochondrial DNA (mtDNA) is more susceptible to damage than nuclear DNA
(nuDNA) due to oxidative metabolism in mitochondria (Lee et al., 2010a). Thus, we
examined whether prohibitin binds to mitochondrial or nuclear DNA to determine its
molecular chaperone function. We tested the hypothesis that mitochondrial prohibitin
may show different affinity toward mitochondrial DNA versus nuclear DNA. Using a
native gel assay, we examined whether prohibitin in mitochondrial and nuclear extracts
bind to mtDNA and nuDNA. It was found that mitochondrial prohibitin forms proteinmtDNA complex at 720 kDa as shown in Figure 4.11 lane 2 and 3, whereas it forms 150
kDa complexes with nuclear DNA. Nuclear prohibitin showed the weaker interaction
with mitochondrial and nuclear DNA, forming mixtures of 720 and 150 kDa complexes
(Figure 4.10, lane 5-8). Higher concentration of mtDNA and nuDNA with nuclear
prohibitin breaks molecular interactions showing monomeric prohibitin at 32 kDa (Figure
4.11, lane 6 and 8). To confirm prohibitin-mtDNA interaction, we used the sedimentation
assay using mitochondrial prohibitin with or without mtDNA. Prohibitin from
mitochondrial fraction formed high density complex with mtDNA (Figure 4.11).
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Figure 4.10 Cholesterol dependent prohibitin expression from RPE. ARPE-19 cells were
treated with different concentrations of cholesterol for 16 hrs. Proteins were separated by
SDS-PAGE and prohibitin expression is visualized by western blotting analysis.
Increased cholesterol levels significantly down regulate the PHB1 expression whereas
PHB2 levels show less sensitivity towards elevated cholesterol levels.

Figure 4.11 Prohibitin-DNA binding analysis. Sub cellular mitochondrial and nuclear
PHB fractions from bovine retina were intercross mixed with gel-purified mitochondrial
(mt) and nuclear (nu) DNA extracted from bovine retina. DNA-protein complexes were
separated by native-PAGE and prohibitin expression is visualized by western blotting
analysis.
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Prohibitin-Binding Proteins
To understand the downstream signaling of prohibitin in various subcellular organelles,
prohibitin-binding proteins were determined using immunoprecipitation (IP) analysis.
(Figure 4.12-13). ARPE-19 cells were treated with or without oxidative stress (200 mM,
t-BuOOH) and 49 putative prohibitin binding proteins in elution fractions were analyzed
by MALDI-TOF mass spectrometry. IP with preimmune serum and a blank gel with
trypsin digestion were used as negative controls and prohibitin-p53 binding was
considered as a positive control (data not shown). Identified protein name, accession
number, probability MOWSE score, sequence coverage, predicted mass, predicted pI,
and identified peptide number were presented. Among these, a couple of cytoskeletal
proteins, including kinesin, actin and myosin head motor domain, were found in both
control and oxidative stress. Actins are highly conserved proteins that are involved in cell
motility and structural integrity. It has a nucleotide binding domain which is crucial in the
proper function of ion channels. Nucleoporin-like protein at 86 kDa transports
macromolecules between the nucleus and cytoplasm. Nucleoporin and lamins are
speculated to be involved in the translocation of prohibitin between the nucleus and
mitochondria. PI3K, p85 binding domain, suggests that prohibitin is involved in PIP3
pathway to regulate lipid and insulin signaling. Nuclear mitotic apparatus protein 1
isoform (NUMA) belongs to the same coiled coil family as prohibitin, myosins, lamins
and intermediate filaments. NUMA is proposed to play a role in maintaining and
establishing nuclear structure, possibly as a structural component of the nuclear matrix.
Next, we used HRP (human retinal progenitor) cells to gain better understanding whether
prohibitin in the retina may have similar function or binding partners. Actin and myosin
binding of prohibitin may suggest mitochondrial DNA maintenance function of prohibitin
in the retina. Pleckstrin (PH) domain containing protein, PH2, Rab21 binding implies
prohibitin-induced specific inositide and Ras signaling in the retina.
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Figure 4.12 Immunoprecipitation of PHB interacting proteins. Coomassie stained gel of
immunoprecipitated proteins from control ARPE-19 cells (lysate) with anti-PHB
antibody. Cells were harvested, lysed followed by Co-IP and separated by SDS-PAGE.
Proteins in the W1 to W3 represents wash fractions; E1 to E3 represents elution fractions;
Eb represents the protein elution by immunoprecipitated boiling protein-A beads with
sample buffer (Eb). Elution fractions showed that the potential binding partners of PHB,
which were further processed for In-gel digestion and MALDI-TOF mass spectrometry.
Coomassie stained gel of immunoprecipitated proteins from oxidative stress (200 μM)
treated ARPE-19 cells (lysate) with anti-PHB antibody. Cells were harvested, lysed
followed by Co-IP and separated by SDS-PAGE. Proteins in the W1 to W3 represents
wash fractions; E1 to E3 represents elution fractions; Eb represents the protein elution by
immunoprecipitated boiling protein-A beads with sample buffer (Eb). Protein standard
(marker) represents the size between 10 to 120 kDa. . Elution fractions showed that the
potential binding partners of PHB, which were further processed for In-gel digestion and
MALDI-TOF mass spectrometry.
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Figure 4.13 Co-Immunoprecipitation (Co-IP) of PHB interacting proteins. Coomassie
stained gel of immunoprecipitated proteins from control human retinal progenitor (HRP)
cells (lysate) with anti-PHB antibody. Cells were harvested, lysed followed by Co-IP and
separated by SDS-PAGE. Proteins in the W1 to W3 represents wash fractions; E1 to E3
represents elution fractions; Eb represents the protein elution by immunoprecipitated
boiling protein-A beads with sample buffer (Eb). Elution fractions showed that the
potential binding partners of PHB, which were further processed for In-gel digestion and
MALDI-TOF mass spectrometry. Coomassie stained gel of immunoprecipitated proteins
from oxidative stress (100 μM) treated human retinal progenitor cells (lysate) with antiPHB antibody. Cells were harvested, lysed followed by Co-IP and separated by SDSPAGE. Proteins in the W1 to W3 represents wash fractions; E1 to E3 represents elution
fractions; Eb represents the protein elution by immunoprecipitated boiling protein-A
beads with sample buffer (Eb). Protein standard (marker) represents the size between 10
to 120 kDa. Elution fractions showed that the potential binding partners of PHB, which
were further processed for In-gel digestion and MALDI-TOF mass spectrometry.
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Table 4.1 Potential binding partners of prohibitin from human retinal pigment epithelial (ARPE-19) and human retinal progenitor (HRP) cells.
Band Accession

Protein identified

score

A1

83404899

Kinesin Family member 19 protein

47325

A1

194388398

Myosin head (motor domain)

Mass

PI Peptide

8.2

93161

6.2

7

253758

9.0

110912

8.5

7

Cadherin_repeat (Ca binding site)

633431

10.0

88790

4.7

6

Collagen, partial

189998

11.0

72107

7.3

5

Nucleoporin-like protein

1.95e+6

12.0

86380

6.5

6

2+

%coverage

88

A13

26330300

A16

292352

A18

74187742

A22

2217933

PKU-beta(Serine/Threonine kinases)

2211

7.6

88883

8.9

4

A22

8392959

Beta-1,4-galactosyltransferase 2

3975

15.4

41910

9.4

4

A22 113195686

Lamin-B2

3513

10.9

67319

5.4

4

A23 194388398

Myosin head (motor domain)

9.80e+7

15.1

110912

8.5

12

A25 158259341

PI3-Kinase,p 85 binding domain protein

645600

11.6

124285

6.9

8

A28

40352738

Ion transport protein

306309

18.5

61801

5.5

5

A32

4220898

Transcriptional co-activator CRSP130

441010

8.4

106209

8.5

6

A33

41945518

Tiam1 PH domain lipid binding protein

105719

8.6

99654

8.7

7

A34

38569540

5'-3' exoribonuclease 2 isoform 3

140868

10.6

103802

8.2

7

A34 148705232

Leucine rich repeats,pyrin death domain

179814

9.4

112138

8.0

8

A35

624871

a1(XIX) collagen chain precursor

2.94e+7

12.9

115096

8.4

8

A41

74187742

Nucleoporin-like protein

379387

10.2

86380

6.5

5

A44

62897409

Beta actin variant

2.47e+8

35.5

41723

5.3

10

A45

3603443

Fibrousheathin I

192098

11.7

94617

6.0

5

A45

5834582

E3 ubiquitin-protein ligase TRIM33

66846

8.7

115982

7.1

6

A47 119582405

Cadherin_repeat (Ca2+ binding site)

4.44e+8

A49

Nuclear mitotic apparatus protein 1 isoform CRA

1.85e+7

13278786

14.2
%coverage

88669

5.0

10

109280

8.1

11

Mass

PI Peptide
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Band Accession

Protein identified

H1

194388398

Myosin head (motor domain)

161675

8.6

110912

8.5

7

H4

158256650

Meckelin

1.14e+9

14.3

116422

6.2

11

H5

119603470

Esterase 31, isoform CRA_e

43420

7.7

59890

5.4

4

H6

7019942

5’-3’ Exonuclease

6.28e+6

17.1

63785

9.0

6

H11

11908000

BCL-6 corepressor short isoform

1.78e+7

17.8

107405

8.8

9

H11 119584312

Inositol 1,4,5-triphosphate receptor, type 1

1.47e+6.

8.8

117553

6.2

6

H13 119612108

Transmembrane protein 67, isoform CRA_b

752714

10.2

109958

6.2

6

H14

5882259

Genethonin 3

9.41e+6

15.3

89342

5.2

8

H19

14250401

Actin, beta, partial

4.89e+6

32.3

41005

5.6

9

H21S 74213524

ACTB protein, partial

1.22e+9

33.6

41751

5.3

10

H23S

2656123

P-53 binding protein

2881

7.4

93501

9.6

4

H26

2102696

Karyopherin beta 3

6.53e+6

13.2

123599

4.8

10

H29 115529728

Guanine nucleotide exchange factor OSTIII

5.98e+6

8.8

123524

5.7

8

H32

Nuclear Pore Protein 107

2.40e+11

19.2

79971

5.2

8

H34 272982598

Anti-HIV-1 gp120 immunoglobulin heavy chain

4.02e+8

22.4

51810

8.1

8

H36

5305448

PH domain containing signaling mediator isoform

175808

16.8

70047

5.7

6

H38

39644830

Pleckstrin 2 protein, partial

152085

24.2

39711

9.5

5

34189309

score

18.6

Band Accession

Protein identified

Mass

PI Peptide

H39

Ras related protein Rab-21

38925

33.8

24348

8.1

5

H41 148692949

Leucine rich repeat containing 21

169639

9.6

111679

6.8

5

H44 226958677

Guanine nucleotide exchange factor DSB isoform 3 872951

7.6

123694

5.7

8

H45 148682292

Retinis pigmentosa 1 homolog (human)

5.1

124037

9.5

6

7661922

score

30379

%coverage
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4.4.6 Lipid Binding Pocket in Prohibitin
Controlled translocalization of prohibitin to specific subcellular organelle under stress
condition is a critical event for apoptosis, proliferation, lipid metabolism, and aging. We
speculate that prohibitin translocalization and trafficking might be influenced by specific
lipid binding sequence and temporal lipid concentration. We hypothesized that prohibitin
may have a putative lipid binding domains that include conserved basic amino acids. To
test our hypothesis, we examined whether prohibitin has any homologous lipid binding
domain

or

conserved

basic

amino

(http://www.sanger.ac.uk/software/pfam),

acids

Ensembl

using

PFAM

database

human

genome

browser

(http://www.ensembl.org/homo_sapiens), and support vector machine-based functional
prediction (http://jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi).

Lipid binding modules,

including C1, C2, pleckstrin homology (PH), Phox homology (PX), Fab1-Yop-Vac1Eea1 (FVVE), Epsin amino-terminal homology (ENTH), Four-point-one-Ezrin-RadixinMoesin (FERM) domains, ANTH, BAR, PDZ, tubby, START, and Src homology 3
(SH3) domains, were examined. Previously we demonstrated that prohibitin has a strong
affinity with phosphatidylinositol 3,4,5-triphosphate (PIP3) and cardiolipin under various
stress conditions. Prohibitin also has low affinity toward PI (4)P, PI (4,5)P2, 3sulfogalactosylceramide, phosphatidic acid and phosphatidylserine. PIP3 interacts with
PX domain containing proteins that include p40phox, p47phox, phospholipase D1 (PLD1),
SNX6, and cytokine-independent serine/threonine kinase (CISK or SGK3). Multiple
sequence alignment demonstrated that two of the most well conserved basic amino acids
in prohibitin are R35, R43, R72 that are homologous to K75, R90, and R135 of SGK3,
which represent phosphoinositide binding pocket (Figure 4. 8). R41 and R72 in prohibitin
are also homologous to R43 and R90 in the PX domain of p47phox (data not shown).
Other conserved basic residues are K11, K83, R97, R105, R143, R157, K207, and K208
with SNX6 and SGK3, both known as phosphoinositide binding proteins. We compared
the PX domain of prohibitin with the known p47phox structure. The conserved basic amino
acid sequence is homologous to the cationic residues in the putative PIP3 binding pocket
(R41, R72) of p47phox (data not shown). Phosphate groups in PIP3 may interact with
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three arginine residues, R41/43 and R72 of prohibitin. A conserved F42 (F44 in p47phox)
seems essential for the inositide ring interaction to make U shape PIP3 binding pocket.
Two conserved proline residues, P64 and P98, suggest a β turn structure, mimicking the
second anion-binding site of p47phox (P73, P76). Many more conserved basic residues that
include R143, R157, K207, and K208, imply a putative second anion-binding site (e.g.
cardiolipin) at C terminus.
4.5 Discussion
The current study is aimed to determine whether prohibitin is downregulated in the RPE
leading to mitochondrial dysfunction in AMD. Decreased prohibitin may modulate lipid
metabolism, transcriptional activation and RPE apoptosis to accelerate AMD pathway.
We tested our working hypothesis of inverse correlation of prohibitin expression and
AMD using in vivo model, prohibitin knockdown and molecular interaction assays. Our
data demonstrates that prohibitin is depleted in the RPE during AMD pathogenesis. To
determine the downstream mechanism of prohibitin signaling at the molecular level, we
examined various prohibitin-binding assays, including mitochondrial/nuclear DNA,
phospholipid, and immunoprecipitation. As the susceptibility of the RPE and retina to
oxidative stress is different, altered expression of prohibitin in the RPE and the retina are
anticipated in the diabetic and aging model. Previously, our data showed that prohibitin is
differentially expressed in the retina and RPE as an oxidative stress biomarker that
significantly changed its concentration in light induced stress, aging and diabetic
conditions (Lee et al., 2011). Further, we demonstrated that 1) stress-dependent
translocalization of prohibitin between the nucleus and mitochondria as a retrograde
signal, 2) PIP3 and cardiolipin binding changes under stress, 3) phosphorylation in the
nucleus and interaction with the tumor suppressor p53, 4) accelerated apoptosis by
prohibitin depletion. The changes in the expression and localization of prohibitin induced
by reactive oxygen species are crucial events for mitochondrial integrity. Prohibitin is a
lipid metabolism switch that binds to PIP3 and cardiolipin in a stress-dependent manner
(Sripathi et al., 2011c). We speculated that prohibitin may contain lipid binding domain,
including conserved basic amino acids. The rationale for examining the prohibitin-lipid
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interaction is that prohibitin showed stress-dependent lipid binding properties in vitro.
Changes of prohibitin-lipid and protein interaction in RPE cells under oxidative stress
characterized here will help to identify key elements of apoptotic networks that follow
lipid metabolism and serve as a framework of biochemical pathways for future studies of
AMD. Prohibitin-PIP3 interaction leads to attenuation of insulin signaling (Ande and
Mishra, 2009). PIP3 has a central role in transmitting insulin signaling and may also
provide a platform for protein-protein interaction. PIP3 acts as a signaling molecule in a
variety of cellular processes including cell proliferation, cell motility, metabolism, and
immune response. Prohibitin contains conserved basic amino acid residues as the PX
domain with 25-50% homology. The PX domain is a phosphoinositide-binding domain
with many functions including protein sorting, vesicular trafficking and phospholipid
metabolism. Our multiple sequence alignment shows that prohibitin may have a
phosphoinisitide binding site that may influence PIP3 and cardiolipin binding. Conserved
basic residues are R43, R72, K83, R97, and R105 that are aligned with the p47phox,
SNX6, and SGK3 PX domain. PX domain residues are not highly conserved as shown as
25-50% compared to other PX domain proteins, however, essential basic amino acids
with hydrophobic (F, I, L, A) and structural (P, G) amino acids seems enough to make a
phospholipid binding pocket. A putative secondary pocket also suggests that allosteric or
post-translational modification-dependent, including T/Y phosphorylation and C
palmitoylation, regulatory mechanism on lipid binding. We speculate that the origin of
prohibitin function on metabolism and aging is from altered lipid bindings, including
cardiolipin and PIP3, under stress condition. Prohibitin binds to PIP3/PI(4,5)P2 with 5
fold ratio. In normal conditions, PI (4,5)P2 has higher concentration than PIP3, so strong
PIP3 binding will facilitate PI3K reaction. However, prohibitin modulates this interaction
toward cardiolipin under

oxidative stress, suggesting

switch-off function of

phosphoinositide reaction. Cardiolipin plays an important role in assembly of respiratory
chain complexes, m-AAA protease complex, and the α-ketoglutarate dehydrogenase
complex.

m-AAA

protease

removes

non-assembled

polypeptides

from

inner

mitochondrial membrane. Phosphatidylinositol is a key membrane constituent and a
participant in essential metabolic processes on PI3K pathway. PIP3 stimulates signaling
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pathways involved in cell growth, survival, motility and proliferation. Phosphoinositidebinding proteins are phospholipases, protein kinases, membrane trafficking regulators,
cytoskeletal scaffold, and ion channels. PIP3 binding involves electrostatic interactions
with the negative charges of the phosphate groups on the inositol ring with characteristic
clusters of basic amino acid residues in proteins. Prohibitin is a part of mitochondrial
nucleotide-protein complex to protect endothelial cells against reactive oxygen speciesinduced senescence. Fibroblasts lacking prohibitin show aberrant mitochondrial cristae
and exhibit a decreased resistance toward apoptosis. Apoptotic cells and photoreceptor
discs are eliminated in circadian dependent manner by the phagocytotic mechanism by
RPE. PI(4,5)P2 interventions, both degradation and synthesis, compromise phagocytic
pathway. During phagocytosis, PIP3 and PI3K are regulated for clustering receptors and
actin polymerization. Considering weak binding of PHB PI (4, 5) P2 and strong binding
with PIP3, prohibitin may act as a cell fate determinant by altering lipid interaction under
oxidative stress. Prohibitin has an anti-apoptotic function in mitochondria as the default
function showing high affinity toward PIP3 under normal condition as a positive
regulator of PI3K pathway. Prohibitin may become a transcriptional regulator in the
nucleus under oxidative stress with weaker interaction with PIP3. The dual lipid binding
switch might be essential to regulate RPE cells from uncontrolled proliferation under
oxidative and altered lipid environment on diabetes and aging. Depletion of prohibitin
may affect lipid metabolism in aging- and oxidative stress-dependent manner. Prohibitinmediated signaling, including epithelial migration, reversal of obesity, drug sensitivity,
and longevity, is known (Kolonin et al., 2004a; Rajalingam et al., 2005). Prohibitin was
proposed as an anti-proliferative protein or a tumor suppressor forming a high molecular
complex with prohibitin2 in mitochondria. Localization of prohibitin has been
controversial as being mitochondrial, nuclear, or cell surface possibly due to cell type and
lipid environment. The current study identified the potential binding partners of
prohibitin and their putative functional roles in the retina and RPE. Differential
expression of prohibitin was observed in the postmortem retinas of diabetic retinopathy
(DR), aged, also in the retinas of mouse and rats in vivo. Region-specific expression of
prohibitin with respect to retina (macular and peripheral) and RPE (central and
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peripheral) were observed in the postmortem tissues of AMD. Based on our biochemical
and proteomic analysis, we suggest that prohibitin is a specific lipid binding modulator in
diabetes-induced retinopathy and age-related retinal degenerative diseases. Prohibitin
showed strong affinity with PIP3 compared to PI(4,5)P2. This interaction may facilitate
the forward reaction of PI3K pathway in normal and stress conditions. Prohibitin
interacts with cardiolipin as a retrograde response to activate mitochondrial proliferation.
Lipid binding switch mechanism of prohibitin may suggest the origin of prohibitin effect
on energy metabolism and age-related diseases.
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CONCLUSION
In this study, we demonstrate that mitochondrial chaperone and anti-apoptotic protein
prohibitin is translocalized from mitochondria to nucleus in response to oxidative stress.
Mitochondrial-nuclear (MT-NU) communication by prohibitin shuttling involves lipid
interaction changes such as PHB-phosphatidylinositol phosphates (PIP3) in normal
condition compared to PHB- cardiolipin binding and nuclear prohibitin phosphorylation
during oxidative stress. Prohibitin interaction with p53 reveals the role of nuclear PHB
in transcriptional regulation. Our knockdown approach using prohibitin specific small
interfering RNA (siRNA) resulted in the upregulation of pro-apoptotic proteins (AIF,
caspases-9, BAK) and downregulation of anti-apoptotic protein (Bcl-xL). The
phenotypic sub cellular organelle changes provide valid evidence that prohibitin is
involved in the anti-apoptotic signaling to protect the RPE from oxidative damage.
Our data reveals that, concentration of NO generation is elevated during intense light
exposure, oxidative damage and re-oxygenation towards RPE cells. We provide the
evidence that inducible nitric oxide synthase (iNOS) is actively involved in the
production of NO and also increase in protein nitration by the formation of 3nitrotyrosine in the RPE under oxidative stress. We also determined that upregulation of
PP2Ac (catalytic subunit) phosphorylation negatively correlates with the vimentin
phosphorylation under oxidative stress. NO production in the cells enables the down
regulation of PP2Ac phosphorylation to further achieve vimentin filament stabilization
during stress induction. The timely generated NO may indirectly influence the
cytoskeletal

dynamics

and

apoptotic

pathways

via

phosphorylation

or

dephosphorylation signaling.
Further, we have identified the potential binding partners of prohibitin in the retina and
RPE cells under oxidative stress. Increased levels of prohibitin in the central (macular)
and peripheral retina, and decreased levels of prohibitin in the central (macular) and
peripheral RPE were identified from age-related macular degeneration (AMD) donor
eyes. We also found that prohibitin in the retinas of diabetic retinopathy is increased
96

from rats, mouse and humans. On the other hand, increase in expression of prohibitin
was observed in the aged retinas of rats, mouse and human as well.
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FUTURE DIRECTIONS
We found that prohibitin is up regulated in the retina but down regulated in the RPE of
age-related macular degeneration (AMD) and diabetic retinopathy (DR). The tissue
specific prohibitin expression and regulation is needed to be clearly understood in
transgenic animal models. Retinal neo-vascularization is the common pathological
feature in diabetic retinopathy (DR), AMD and retinopathy of prematurity (ROP), so
understanding the role of prohibitin during hypoxia induced retinal angiogenesis may
reveal its crucial function in retinal degenerative diseases. Identification of prohibitin
interacting protein network will unveil the various signaling pathways that are involved
in prohibitin expression and regulation in disease condition. Sequence-specific DNAprohibitin binding is crucial in understanding the nuclear functions of prohibitin in the
retina and RPE. We observed that nuclear prohibitin is phosphorylated, however, other
post translational modifications such as acetylation, palmitoylation, and glycosylation
need to be confirmed. We measured the concentration of nitric oxide generated from
RPE cells in vitro, however, the ideal levels of NO required for RPE protection from
apoptosis need to be established. As the RPE cells release NO under stress response,
determining the beneficial or deleterious effects of such NO on neural retina is highly
necessary. NO signaling studies need to be performed in age-related macular
degeneration, diabetic retinopathy and aged models in vivo. In our study, we mainly
focused on biochemical and proteomic approaches to understand the involvement of
various proteins during retina and RPE apoptosis. Identification of complete protein,
lipid binding network, and detailed phosphorylation signaling for target proteins is
required to understand the mechanism of retina and RPE cell death.
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